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SUMMARY 
 
AEC (Ankyloblepharon- Ectodermal defects- Cleft lip/palate 
syndrome) syndrome is an autosomal dominant disorder mainly 
characterized by ectodermal dysplasia, skin erosions and cleft lip 
and/or palate. This disorder is caused by missense mutations in the 
Sterile Alpha Motif (SAM) domain and frameshift mutations in the 
Post-SAM (PS) domain of the transcription factor p63, a crucial 
regulator of embryonic development of stratified epithelia. 
To fully understand the molecular mechanisms associated with the 
pathogenesis of AEC syndrome, we analyzed transcription ability and 
DNA binding capacity of AEC causative p63 mutant proteins in 
heterologous system. L514F, G534V, C519R, D544Y, mutations 
involving SAM domain, and E570fsX94 and N620fsX44, mutations in 
the PS domain, showed an impaired transactivation ability consequent 
to a reduced DNA binding capacity, both when transfected alone and 
in combination with wild-type protein.  
To further explore the role of the two C-terminal domains of p63 
isoform, that are involved in AEC syndrome, we obtained two 
deletion p63 mutants that lack alternatively SAM (p63SAM) or PS 
(p63PS) domains, and tested transactivation and DNA binding. We 
found that the SAM domain, but not the PS one, is strongly involved 
in these functions, since the deletion of the whole domain impaired 
transactivation and DNA binding ability, in spite of an intact DNA 
binding domain of p63.  
To test the physiological significance of our findings, we analyzed the 
effect of an endogenous L514F p63 mutant in primary keratinocytes. 
To this aim we took advantage of a conditional knock-in mouse model 
(p63
+/floxL514F
) recently generated in our laboratory. In accordance with 
previous results, also in its natural context AEC p63 mutant showed a 
reduced DNA binding and decresed expression levels of different p63 
target genes, such as Fgfr2, IRF6, Dsc3, Dsp, Krt5 and Krt14, both in 
homozygous and in heterozygous mutant keratinocytes.  
Finally, we tested the effects of L514F p63 mutant in vivo mating 
p63
+/- mice with knock-in p63
+/L514F
 ones, previously generated in our 
laboratory that closely resembles the human disease but died soon after 
birth for cleft palate, to obtain p63
-/L514F 
mice. At E18.5 we observed 
epidermal, limbs and craniofacial development defects and with ChIP 
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assays on E14.5 embryos skin an impairement in DNA binding ability 
in p63
-/L514F 
mice was confirmed.  
These results shed light on the mechanisms underlying AEC 
syndrome, since all the analyzed mutant p63 proteins show an 
impairment in DNA binding ability, moreover this reduction is 
observed in heterozygous keratinocytes suggesting that L514F p63 
mutant acts in a dominant negative manner, forming with wild-type 
proteins tetramers not well working. Using p63 deletion mutants we 
demonstrate that an intact SAM domain is required for transactivation 
and DNA binding ability in Np63 context, while large 
rearrangements of PS domain, such as frameshift mutations but not 
whole domain deletion, show same effects, suggesting that this 
domain is not required for the described p63 functions. Finally, with 
in vivo experiments we demonstrate the crucial role of -isoform of 
p63 in epidermal, limbs and craniofacial development and that its 
mutations, although in the presence of intact  and  isoforms, 
strongly impaired development and DNA binding capacity, which 
explains pathogenesis of AEC syndrome.        
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RIASSUNTO 
 
La sindrome AEC (Ankyloblepharon- Ectodermal defects- Cleft 
lip/palate syndrome) è una malattia autosomica dominante, 
caratterizzata principalmente da displasia ectodermica, erosioni 
cutanee e labioschisi e/o palatoschisi. Questo disordine è causato da 
mutazioni missenso localizzate nel dominio Sterile Alpha Motif 
(SAM) e mutazioni frameshift nel dominio post-SAM (PS) del fattore 
di trascrizione p63, un regolatore fondamentale dello sviluppo 
embrionale degli epiteli stratificati. 
Per meglio comprendere i meccanismi molecolari associati alla 
patogenesi della sindrome AEC, abbiamo analizzato la capacità 
trascrizionale e di legame al DNA di mutanti di p63 causativi della 
patologia in questione in un sistema eterologo. L514F, G534V, 
C519R, D544Y, mutazioni che coinvolgono il dominio SAM, e 
E570fsX94 e N620fsX44, mutazioni nel dominio PS, hanno mostrato 
una ridotta capacità di transattivazione conseguente ad una ridotta 
capacità di legare il DNA, sia quando trasfettate da sole che in 
combinazione con la proteina wild-type. 
Per esplorare ulteriormente il ruolo dei due domini C-terminali 
dell'isoforma  di p63 coinvolti nella sindrome AEC, abbiamo 
ottenuto due mutanti di delezione di p63 che mancano 
alternativamente del dominio SAM (p63SAM) o PS (p63PS) e ne 
abbiamo testato transattivazione e legame al DNA. Abbiamo così 
trovato che il dominio SAM, ma non il PS, è coinvolto in queste 
funzioni, in quanto la sua delezione compromette fortemente le attività 
di Np63, a dispetto di un dominio di legame al DNA ancora intatto. 
Per testare il significato fisiologico delle nostre scoperte, abbiamo 
analizzato l'effetto del mutante di p63 L514F endogeno in 
cheratinociti primari. 
A questo scopo abbiamo approfittato di un modello murino 
condizionale knock-in (p63
+/floxL514F
) recentemente generato nel nostro 
laboratorio. In accordo con i risultati precedentemente ottenuti, anche 
nel suo contesto naturale il mutante di p63 causativo della sindrome 
AEC ha mostrato un ridotto legame al DNA e diminuiti livelli di 
espressione di diversi geni bersaglio di p63, come Fgfr2, IRF6 , Dsc3, 
Dsp, Krt5 e Krt14, sia in cheratinociti omozigoti per la mutazione che 
in quelli eterozigoti. 
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Infine, abbiamo testato gli effetti della mutazione L514F di p63 in 
vivo accoppiando topi p63
+/-
 con quelli knock-in p63
+/L514F
, 
precedentemente generati nel nostro laboratorio, i quali ricapitolano la 
patologia umana ma muoiono poco dopo la nascita per palatoschisi, 
per ottenere topi p63
-/L514F
. Allo stadio embrionale E18.5 abbiamo 
riscontrato difetti nello sviluppo cranio-facciale, dell'epidermide e 
degli arti e tramite saggi di immunoprecipitazione della cromatina 
effettuati su pelle di embrioni a E14.5  abbiamo confermato una 
riduzione della capacità di legame al DNA in topi p63
-/L514F
. 
Questi risultati chiariscono i meccanismi sottostanti la sindrome AEC, 
dal momento che tutte le proteine di p63 mutanti analizzate mostrano 
un compromessa capacità di legame al DNA, questa riduzione si 
osserva nei cheratinociti omozigoti per la mutazione ma anche negli 
eterozigoti, ciò suggerisce che  quanto meno il mutante L514F agisce 
da dominante negativo, formando con la proteina wild-type tetrameri 
non funzionanti. Utilizzando mutanti di delezione di p63 abbiamo 
dimostrato che un dominio intatto SAM è richiesto per la corretta 
transattivazione e per il legame al DNA nel contesto della Np63, 
mentre grandi riarrangiamenti del dominio PS, come mutazioni 
frameshift ma non la delezione totale del dominio, mostrano gli stessi 
effetti, suggerendo che questo dominio non è richiesto per le funzioni 
di p63 sopra descritte. Infine, con esperimenti in vivo abbiamo 
dimostrato il ruolo cruciale dell' isoforma  di p63 nello sviluppo 
degli epiteli stratificati, degli arti e nello sviluppo cranio-facciale, e 
che mutazioni che la coinvolgono, pur in presenza di isoforme di p63 
 e  funzionanti, compromettono fortemente il suo ruolo di fattore 
trascrizionale, spiegando le basi della patogenesi della sindrome AEC. 
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1. INTRODUCTION 
 
1.1 Epidermis and its development 
The skin is the first barrier that protects the body from 
hazardous substances such as chemical, infectious, and mechanical 
stressors. Mammalian skin has two major compartments, the dermis 
and the epidermis, which are separated by a basement membrane (1). 
This two compartments function cooperatively and together are 
responsible for the development of epidermal appendages, including 
hair follicles and mammary glands (2). The epidermis is the outermost 
component of the skin and consists of four distinct cell layers, from 
bottom to top: the basal, the spinous, the granular and the stratum 
corneum or cornified layer (1-Fig. 1). The stratified squamous 
epithelium is maintained by cell division within the basal layer. 
Differentiating cells slowly move outwards toward the stratum 
corneum, where anucleate corneal cells are continuously shed from 
the surface (desquamation). In normal skin the rate of production 
equals the rate of loss, taking about two weeks for a cell to migrate 
from the basal cell layer to the top of the granular cell layer, and an 
additional two weeks to cross the stratum corneum (3).  
The epidermis, like other stratified epithelia, has a self-renewing 
capacity throughout life, and this continuous turnover is mediated by 
stem cells in the basal layer of the interfollicular epidermis (4) and in 
the bulge region of the hair follicle (5). Epidermal stem cells give rise 
to daughter stem cells and to transit amplifying cells, which constitute 
the major cell type in the basal layer of the developing and mature 
epidermis (4, 6). After a few rounds of cell division, transit amplifying 
cells permanently exit from the cell cycle, and initiate a terminal 
differentiation program. Further epidermal maturation occurs when 
spinous cells differentiate into granular cells and finally, cornified cell 
envelopes are assembled by cross-linking of structural proteins and 
lipids (7). The process of keratinocyte differentiation in mature 
epidermis mimics the initial development and maturation of 
keratinocytes during embryogenesis. Epidermal keratinocytes derive 
from the single-layered surface ectoderm and develop when the 
underlying mesenchyme releases an inductive signal (8). So epidermal 
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development and differentiation are multi-step processes, which 
involve the sequential action of many molecules. 
One gene that is essential for early stages of skin development is the 
transcription factor p63 (9,10,11). 
 
 
Figure 1: Epidermis. Mammalian skin consists of the epidermis and 
dermis, separated by a basement membrane. The epidermis is a 
stratified squamous epithelium composed by, from bottom to top: 
stratum basale consisting of proliferating, transit- amplifying cells 
interspersed to epidermal stem cells, stratum spinosum, stratum 
granulosum and corneum. p63 is predominantly expressed in the basal 
layer of the epidermis, it is downregulated upon keratinocyte 
differentiation. Copyright 2001 Benjamin Cummings, an imprint of 
Addison Wesley Longman, Inc. 
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1.2 The transcription factor p63 
p63 belongs to the p53 gene family consisting of three genes, 
p53, p63, and p73, that show significant sequence homology (12) and 
share three functional domains commonly found in transcription 
factor: an N-terminal transactivation domain which shares 25% 
homology with N-terminal part of p53, a central DNA binding domain 
which shares 65% of homology with the corresponding p53 domain 
and C-terminal tetramerization domain, which shares 35% of 
homology with the oligomerization domain of p53. In addition, all 
family members share some biological functions and bind to a 
canonical p53-binding site, thus controlling the expression of a subset 
of p53 target genes (12,13). p63, p53 and the third member p73, 
constitute a family of key transcriptional regulators in cell growth, 
differentiation and apoptosis. 
While p53 is a major player in tumorigenesis (14), p63 and p73 appear 
to have pivotal roles in embryonic development (9,15). More in detail, 
p63 has a crucial role in embryonic development of stratified 
epithelia. 
The p63 gene encodes a tetrameric transcription factor, of 16 exons 
located on chromosome 3q28, that can be expressed in at least six 
isoforms with widely different transactivation potential that share an 
identical DNA binding domain (16). Alternative transcription start 
sites (TSS) give rise to transactivation (TA) isoforms, encoding 
proteins with a canonical transactivation domain similar to p53, and 
N isoforms containing an alternative transactivation domain (17, 16). 
Due to the absence of the typical N-terminal transactivation domain, 
Np63 isoforms were initially believed to be transcriptionally inactive 
(16). Consistent with this initial prediction and since Np63 isoforms 
retain the oligomerization and DNA binding domains, it is plausible 
that they act as dominant-negative inhibitors of TAp63 isoforms 
during epidermal development (11). A possible mechanism is due to 
the formation of transcriptionally inactive N-TA heterotypic or 
homotypic tetramers (composed of either all-TA or all-N monomers) 
that compete for the same DNA binding sites. Np63 isoforms, 
however, are also able to induce target gene expression in cell lines 
and in primary keratinocytes, suggesting that Np63 isoforms may 
perform multiple roles in the developing and mature epidermis (18, 
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19, 20). This is possible thanks to existence of two cryptic 
transactivation domains in Np63 isoforms: a region encompassing 
the first 26 N-terminal amino acids named TA* domain and a prolin 
rich sequence corresponding to exon 11/12 (21). 
In addition to the use of two different transcription start sites the 
complexity of p63 transcripts is increased by alternative splicing at the 
C-terminus, which gives rise to three different carboxyl termini, 
termed , and  (16). Only p63 isoforms, the longest p63 
isoforms, contain a sterile alpha motif (SAM) domain (22, 23) and a 
post-SAM (PS) domain, which has been shown to function as a 
transcriptional inhibitor domain (TID) (21,24- Fig. 2).  
The most abundant isoform Np63 is expressed from cells of the 
basal layer of epidermis (16). Np63α is one of the first genes to be 
specifically expressed in the surface ectoderm prior to Krt5 and Krt14 
expression at E7.5-E8 and it continues to be expressed during skin 
development and in the basal proliferative layer in postnatal life (11, 
25, 16). Whereas p63 is predominantly expressed in the basal layer of 
the epidermis, it is downregulated upon keratinocyte differentiation 
both in vitro and in vivo (26-31, 10- Fig. 1). In the basal layer, p63 is 
mainly involved in maintaining cell proliferation and cell adhesion 
(13, 11, 32, 33). It has been proposed that p63 plays a dual role in 
keratinocyte differentiation, as it is required for initiating epithelial 
stratification (11, 28, 33), whereas concurrently it inhibits the 
expression of some differentiation markers (19, 28).  
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
5 
 
 
 
Figure 2: p63 gene. (A) Structure of p63 gene with the different 
transcription start sites and C-terminus isoforms. (B) Comparison 
between p53, p63 and p73 proteins. The schematic structure of p63 
and p73 is shown, including the transactivation domain, the DNA-
binding domain, the oligomerization domain, the steril  motif (SAM) 
and the post-SAM domain (PS). The percentage of identity is 
indicated for each domain. (Adapted from Yang et al., On the 
shoulders of giants:p63, p73 and the rise of p53, TRENDS in 
Genetics, 2002) 
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1.3 The -terminus 
 
The C-terminal region of p63 and p73 is coded by three (p63) to 
four (p73) additional exons, not present in p53, that are subject to 
alternative splicing, yielding different proteins with different 
biological properties (16, 34, 35). The full-length α-isoform of p63 
and p73 contains at the C-terminal a structural module known as 
sterile-alpha motif (SAM) and a post-SAM (PS) domain, which is 
absent in all other isoforms.  
While p63 and p63 display p53-like functions, p63 has little or no 
p53 like activity, suggesting that these C-terminal domains could be 
responsible for those functional differences (23, 36). 
 
- SAM domain: 
SAM domains are among the most abundant protein-protein 
interaction motifs (~70-amino acid) in organisms from yeast to 
humans (more than 1300 SAM-containing proteins in all genomes). 
Although SAM domains adopt similar domain structure, they are 
remarkably versatile in their binding properties. Such versatility earns 
them functional roles in myriad biological processes. 
SAM domains are usually found in the context of larger multidomain 
proteins and may be found in all cellular compartments, implying 
roles in complex and wide-ranging cellular processes. These domains 
are found in a wide variety of proteins involved in cell signaling, in 
developmental regulation, signal transduction and transcriptional 
activation, and repression (38) including the Eph family of tyrosine 
kinase receptors (39, 40), the ETS family of transcription factors (41), 
polyhomeotic proteins (41), diacylglycerol kinases (42), liprins (43), 
the connector enhancer of KSR (44), serine-threonine kinases, adapter 
proteins, and others (38). Defects in the SAM domains of proteins 
have been observed in a number of human diseases (45-47), for 
example chromosomal translocation of the ETS family transcriptional 
regulator TEL (translocation Ets leukemia), a SAM-domain 
containing protein, has been frequently linked to human leukemias 
and it is thought that the diseases arise because SAM-mediated 
oligomerization constitutively activates mitogenic proteins (48-50) 
and missense mutations in the SAM domain of p63 cause AEC 
(Ankyloblepharon Ectodermal defects Cleft lip/palate) syndrome 
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(OMIM 106260), a rare autosomal dominant disorder characterized by 
ectodermal dysplasia and orofacial clefting, and Rapp Hodgkin 
syndrome (RHS, OMIM 129400), very similar to AEC one, for a still 
unknown reason. 
The common mechanism of interaction is homo- and hetero-
oligomerization among similar SAM domains (51, 52), but it can also 
mediate intermolecular association with nucleic acids, lipids or other 
proteins not containing SAM domain (38-53).  
The SAM domain in p63 is encoded by exons 13 and 14 in the p63 
gene (16). The solution structure of the C-terminal domain of human 
p63 (505-579) was solved through NMR spectroscopy (54). The 
resulting structure shows a monomer with the characteristic five-helix 
bundle topology observed in other SAM domains (38). It includes five 
tightly packed helices with an extended hydrophobic core to form a 
globular and compact structure (54), helix 1 (α1; residues 514–521), 
helix 2 (α2; residues 527–533), a short 310 helix (H3; residues 538–
542), helix 4 (α4; residues 546–551), and helix 5 (α5; residues 556–
573). A short and distinct -sheet brings together the N-terminus and 
the third 3
10 
helix and the two antiparallel helices 1 and 5 form the 
hydrophobic core with the other three helices (Fig. 3). 
A sequence alignment of p63- and p73-like SAM domains in different 
organisms highlights the importance of several residues. The aliphatic 
isoleucine and leucine residues (I549, L553, L556, I573, I576, L584, 
L587, I589, I597 and I601) that are part of a compact hydrophobic 
core are highly conserved in all SAM domains. G557 is also 
conserved suggesting an important role in forming a turn before the C-
X-X-C motif. Interestingly, this sequence is not always present and 
can be replaced by an L-Q ⁄ G-A-Y motif. Several surface-exposed 
aspartates, lysines, arginines and serines are also highly conserved. 
The two highly conserved residues F552 and F565 participate in the 
formation of the hydrophobic core. F593 is partially solvent exposed 
and can be substituted for either histidine or tyrosine in other SAM 
domains. The fully conserved tryptophan at position 598 in both p63 
and p73 SAM is solvent exposed, whereas in homologous SAM 
domains it participates in hydrophobic core formation. Most of the 
conserved hydrophobic residues appear to be involved in stabilizing 
the fold, although some of the solvent-exposed residues may have a 
functional role. The p63 SAM domain differs from p73 by 
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containing a free cysteine (C547) instead of a proline, possibly 
helping in the formation of a small -sheet region, and the C-terminus 
of p63 SAM is significantly longer (55). 
Unlike the other SAM domains neither p63 nor p73 SAM domains are 
able to form homodimers through their SAM domain. One possibility 
is that the SAM domains of p63 and p73 interact with the SAM 
domain of other proteins or with proteins that do not have a SAM 
domain at all (46). 
Very little is known about the function of the SAM domain in p63 and 
very few interactors have been discovered, such as ABBP1 (apobec-1-
binding protein-1) and Scaf4/rA4 (56) or Cables1 (cyclin-dependent 
kinase (Cdk) 5 and Abl enzyme substrate 1) (57). 
Both ABBP1 and Scaf4/rA4 are RNA-binding proteins that function 
in RNA processing and play a critical role in mRNA splicing. These 
proteins are involved in several RNA-related biological processes 
such as transcription, pre-mRNA processing, mRNA export from the 
nucleus to the cytoplasm, and mRNA translation. However, the major 
role of the hnRNP proteins is regulation of mRNA splicing. The 
physical interaction between ABBP1 and the SAM domain of p63 led 
to a specific shift of FGFR-2 (fibroblast growth factor receptors-2) 
alternative splicing toward the K-SAM isoform essential for epithelial 
differentiation. AEC mutants completely abolished this interaction 
thus leading to the inhibition of epithelial differentiation and accounts 
for the AEC phenotype (56).  
Cables1, a Cdk-interacting protein, protects p63 from ubiquitin-
mediated proteasomal degradation through direct physical interaction 
with the TA and SAM domains of TAp63 and with Np63. 
Cables1 stabilizes p63 by blocking ubiquitin-mediated proteasomal 
degradation of the protein. This process is required for maximal 
stabilization of TAp63 in female germ cells, and the subsequent 
death of these cells, after exposure to a genotoxic stress in vivo (57).  
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Figure 3: SAM domain. (A) Multiple sequence alignment of SAM 
domains of p63 with SAM domains of other proteins. The five helices 
are indicated as H1–H5. The white helices are the helices in the Eph 
receptors and the yellow parts are the helices in p73. Identical and 
similar amino acids are depicted in white boxes. Residues that are 
involved in dimerization are highlighted in blue. The mutated amino 
acids in p63 are indicated with red boxes (Adapted from McGrath et 
al, Hay-Wells syndrome is caused by heterozygous missense 
mutations in the SAM domain of p63, Hum Mol Genet, 2001). (B) 
The crystal structure of p63 SAM domain (Adapted from 
Sathyamurthy et al., Structural basis of p63a SAM domain mutants 
involved in AEC syndrome, The FEBS Journal, 2011) 
 
 
- PS domain, also known as Trans-Inhibitory domain: 
The PS domain, located after the SAM domain, has about its same 
length and shows no homology to any known sequence, aside from the 
equivalent region of p73. 
It is encoded by exon 14 of p63 and can be divided in two 
subdomains: the N-terminal subdomain (the first 45 amino acids) can 
bind and mask the TA domain of the p63 protein blocking its 
transactivation function. For this reason this PS domain is also called 
Trans-Inhibitory Domain (TID). The C-terminal subdomain (the last 
25 amino acids) contains a sumoylation site that is involved in the 
regulation of the p63 protein degradation (58- Fig. 4). 
The NMR studies of the PS domain has shown that this domain lacks 
secondary structure, as characterized by a narrow range of proton 
chemical shifts (24).  
To further understand the role of this domain experiments of GST pull 
down assay have been made with PS domain in the context of TA and 
Np63 isoforms. The results obtained showed that PS domain 
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strongly interacts with three hydrophobic residues of the TA domain 
F16 W20 and L23, conserved in all p53 family and known as MDM2 
binding site (24). This intramolecular interaction obviously involves 
TAp63 that contains both TA and PS domain and forms a closed and 
inactive conformation of the trascription factor. The PS domain of 
Np63 cannot interact intramolecularly since it lacks its own TA 
domain. However, p63 tetramerizes (59), and formation of hetero-
oligomers between TAp63, the most active isoform, and Np63 
could allow PS domain to interact with the TA domain of another 
protein within the tetramer, acting in a dominant-negative manner 
(24).  
Moreover, to demonstrate the inhibitor function of this domain, 
transactivation assay of different p63 isoforms and PS deleted mutants 
have been made and showed that the PS domain is both necessary and 
sufficient for inhibiting the activity of p63 (24).  
Using a similar approach and alanine scanning studies, Straub et al. 
(57) have identified among the amino-acids 605 to 616, highly 
conserved from different species, a core domain responsible for the 
intramolecular interaction with the TA domain, in particular the 
residues FTL (605-607) and TIS (610-612). 
It is known that a S/TQ phosphorylation site, present in the SAM 
domain may trigger a conformational change required for dismantling 
TAp63 intramolecular interaction between the TA and PS domains 
to render the normally transactivation inhibited TAp63 isoform more 
transactivation-competent, as described in oocytes (60).  
Finally, after induction of apoptosis, the PS domain of the p63 
isoforms is cleaved at a single site, amino-acid 458, by activated 
caspases -3. Cleavage of Np63 relieves its inhibitory effect on the 
transcriptionally active p63 proteins, and the cleavage of TAp63 
results in production of a TAp63 protein with enhanced transcriptional 
activity. So, the results of this cleavage is an increased transcriptional 
activity on proapoptotic genes and in general in an increased cellular 
apoptosis (61). 
About the last 25 amino-acids of the PS domain it is known the 
presence of a sumoylation site IKEE (K637) targeting by SUMO-1 
and SUMO-2 (Small Ubiquitin-like Modifier 1 and 2) (62), also 
highly conserved in vertebrate sequences. Surprisingly, however, the 
sumoylation site is missing in invertebrate ones. Further sequence 
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analysis revealed an (I/V)KEE sequence N-terminal to the SAM 
domain in all sequences that miss the C-terminal sumoylation site. 
Investigation of the corresponding TAp63 protein of Mytilus 
trossulus (mt-TAp63) suggested that the elements that control the 
transcriptional activity in mammalian TAp63 are indeed conserved 
in this invertebrate protein (57). Sumoylation can have different 
effects on proteins and can influence stabilization, destabilization, or 
intracellular localization (63-67). In the case of p63, sumoylation has 
been reported to destabilize the protein (62). It does not seem to be 
directly involved in suppressing the intrinsic transcriptional activity of 
p63, but acts indirectly by controlling the intracellular level.  
 
 
 
Figure 4: PS domain. Sequence alignment of C-terminal p63 
sequences of various vertebrate and invertebrate species. Sequences 
N-terminal to the SAM domain to the end of the protein are shown. 
The sequences of the SAM domains themselves are not shown. 
Strictly conserved amino acids are labeled red. The conserved KEE 
sumoylation motif is labeled in blue. This sumoylation sequence is 
located N-terminal to the SAM domain in invertebrate species. 
(Adapted from Straub et al., The C-terminus of p63 contains multiple 
regulatory elements with different functions, Cell Death and Disease, 
2010) 
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1.4 p63-deficient mice 
In the 1999, two independent groups obtained a p63-deficient 
mouse models. Using these models they could explore the unique 
roles of p63 in development of ectodermal derived tissues. 
p63
-/-
 mice die for dehydration shortly after birth and display cleft 
palate, limb truncation and absence of all stratified epithelia, including 
the epidermis (9, 10), suggesting that p63 plays a non-redundant role 
in these tissues. p63-deficient newborns show striking limb defects 
(Fig. 5A). The forelimbs were truncated and hindlimbs were 
completely absent. Phalanges and carpals were absent in all of the 
p63-homozygous mutant, whereas more proximal forelimb structures 
were slightly heterogeneous in the extent of the truncation. The femur 
and all distal skeletal elements were also absent. These defects are 
caused by a failure of the apical ectodermal ridge (AER) to 
differentiate. During embryogenesis, the apical ectodermal ridge, a 
structure required for limb outgrowth along the proximal-distal axis, 
can be seen in the scanning electron micrograph at the junction of the 
dorsal and ventral surfaces of the distal tip of the limbs of E11.5 wild-
type embryos. In contrast, the limb buds of p63-deficient embryos are 
distinctly smaller and misshapen, and there is no morphologically 
distinct AER. Several genes that are important in limb-bud outgrowth 
are not expressed, such as Fgfr8 (a marker of the AER) and Msx-1 
(which expression in the mesenchyme depends on an ectodermal 
signal), or abnormally expressed, such as Lmx-1 (a marker of the 
dorsal limb mesenchyme) (9). Their skin does not progress past an 
early developmental stage: it lacks stratification and does not express 
differentiation markers. The surface of p63-deficient skin is covered 
by a single layer of flattened cells, without the spinosum, granulosum 
and stratum corneum (Fig. 5B). Structures dependent upon epidermal-
mesenchymal interactions during embryonic development, such as 
hair follicles, teeth and several glands, including mammary, salivary 
and lacrimal glands, are absent (9). Defects in the surface epithelium 
of p63-null mice have been ascribed to loss of proliferative potential 
of keratinocyte stem cells (68, 10), and/or altered epidermal 
stratification and cell differentiation associated with reduced 
expression levels of Krt5/Krt14, characteristic of the basal, or 
progenitor, cells of stratified squamous epithelium, and Krt1/Krt10, 
early markers of epidermal differentiation (11, 9, 69). In parallel with 
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suppression of epidermal keratins, loss of p63 results in aberrant 
expression of the simple epithelial keratins Krt8 and Krt18 both in 
vivo and in vitro (11, 33), suggesting that p63 may be involved in 
maintaining an epithelial gene expression program in mammalian 
cells. All these observations suggest that p63 has a crucial role in 
tissue morphogenesis and maintenance of epithelial stem cell 
compartment. 
 
 
 
Figure 5: p63 knock-out mice. (A) The phenotype of p63-deficient 
newborn mice. Matings between p63-heterozygous mice produce 
wild-type and heterozygous offspring that are overtly normal and p63-
deficient mice that have severe limb and skin defects. (Adapted from 
Mills et al., p63 is a p53 homologue required for limb and epidermal 
morphogenesis, Nature, 1999). (B) Defects in stratified epithelial 
differentiation in p63-deficient mice. Right, H&E stained sections of 
perinatal (E17-PI) p63
-/- 
mice lacking squamous stratification in the 
epidermis; arrow shows cellular aggregates seen along the exposed 
dermis. Left, wild-type control H&E sections showing extensive 
stratification. (Adapted from Yang et al., p63 is essential for 
regenerative proliferation in limb, craniofacial and epithelial 
development, Nature, 1999) 
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1.5 p63-associated disorders 
 
Heterozygous mutations in the transcription factor gene p63 are 
causative for several syndromes characterized by various 
combinations of ectodermal dysplasia (ED), orofacial clefting and 
limb malformations. Five different syndromes are already known: 
ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome 
(EEC, OMIM 604292), ankyloblepharon-ectodermal defects-cleft 
lip/palate syndrome (AEC, OMIM 106260), limb mammary syndrome 
(LMS, OMIM 603543), acro-dermato-ungual-lacrimal-tooth 
syndrome (ADULT, OMIM 103285) and Rapp- Hodgkin syndrome 
(RHS, OMIM 129400). Furthermore, two non-syndromic human 
disorders are caused by p63 mutations: isolated split hand/foot 
malformation (SHFM4, OMIM 605289) and recently non-syndromic 
cleft lip (NSCL). All p63-linked disorders are inherited in an 
autosomal dominant manner. 
Ectodermal dysplasia manifests as the abnormal development or 
growth of tissue and structures that are developed from the outer 
embryonal layer, ectoderm. Skin, hair, teeth, nails and several 
exocrine glands, such as sweat and sebaceous glands are usually 
abnormally developed. The epidermis can be very dry and 
hypopigmented and with widespread erosed areas, in extreme cases. 
Hair is often diminished and can be wiry and curly, alopecia is 
sometimes reported. The teeth is often reduced in number and 
malformed, nails can be dystrophic, thickened and discoloured.  Sweat 
glands are absent or reduced, the development and function of 
sebaceous and salivary glands are frequently abnormal, mammary 
glands and nipple are hypoplastic. There are also defects and 
obstruction of the lacrimal ducts. 
The second main characteristic regards limbs. Hands and feet are 
often malformed and have severe median cleft in the palm and/or in 
the sole. Ectrodactyly, the lack of one or more central digits, and 
syndactyly, the fusion of fingers or toes, are present. 
The third hallmark of p63 syndrome phenotype is orofacial clefting in 
the form of cleft lip (CL) and/or cleft palate (CP) (70).  
EEC syndrome is characterized by one or more features of 
ectodermal dysplasia and an highly variability due to the exact nature 
of the causative mutation. EEC patients occasionally also have 
mammary gland/nipple hypoplasia (14%) and hypohidrosis (11%). 
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About two-thirds of these patients have ectrodactyly, and syndactyly 
is also frequent (43%). Cleft lip/palate is present in about 40% of the 
EEC patients, mostly as CL with or without CP (71).  
EEC is mainly caused by point mutations in the DNA binding domain 
(DBD) of the p63 gene. Altogether 34 different mutations have been 
reported, and 20 different amino acids are involved. Only two 
mutations are outside the DNA binding domain: one insertion (1572 
InsA) and one point mutation (L563P) in the sterile a motif domain 
(SAM) (72, 71). The EEC DNA binding domain mutations appear to 
impair the p63 protein binding to DNA. 
AEC syndrome phenotype differs from the other conditions mainly 
by the severity of the skin phenotype, the occurrence of an eyelid 
fusion at birth and the absence of limb malformations. Approximately 
80% of the patients have severe skin erosion at birth, which usually 
will recover in the first years of the life. The eyelid fusion, also called 
ankyloblepharon, is present in about 45% of AEC patients. Nail and 
teeth defects are present in more than 80% of patients, and hair defects 
and/or alopecia are almost constant features (94%). Lacrimal duct 
obstruction is seen in 50% of patients, whereas mammary gland 
hypoplasia and hypohydrosis occur occasionally (both 13%). 
Interestingly, almost 40% of patients have hearing impairment and 
genito-urinary defects. Cleft lip is present in 44% and cleft palate in 
about 80% of cases. Limb malformations are almost absent. 
Ectrodactyly has never been reported, but 25% of patients has only 
mild syndactyly (71). 
RHS mimics AEC very much, the differences are the absence of 
ankyloblepharon in RHS and the more severe skin phenotype in AEC.  
The strong overlap between AEC and RHS suggest that they are 
variable manifestations of the same clinical entity (71, 73). AEC and 
RHS mutations are located in the C-terminus of the p63 protein. They 
are either point mutations in the SAM domain or deletions in the SAM 
or PS domains (46, 47, 72, 74-82). 
EEC and AEC/RHS syndromes are good examples of a strong 
genotype – phenotype association. 
A consistent feature of LMS is the mammary gland and/or nipple 
hypoplasia (100%). Lacrimal duct obstruction and dystrophic nails are 
frequently observed (59 and 46% respectively), hypohydrosis and 
teeth defects are detected in about 30%, but other ectodermal defects 
such as hair and skin defects are rarely detected if at all. About 70% of 
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LMS patients have similar limb malformations as in EEC syndrome, 
and about 30% orofacial clefting, notably always in form of cleft 
palate (74). Mutations in LMS are located in the N- and C-terminus of 
the p63 gene. 
About ADULT syndrome, teeth, skin, nail, hair and lacrimal duct 
defects are constantly present in ADULT syndrome (100, 91, 100%, 
53% and 67%, respectively). A point mutation in exon 8, changing 
R298 in the DNA binding domain into either a glutamine or a glycine 
has been found. While EEC syndrome mutations in the DNA binding 
domain impair the binding of p63 protein to DNA (72), arginine 298 
is not located close to the DNA-binding interface, and mutation of this 
arginine does not affect DNA binding (83). Two other mutations are 
located in the N-terminus. 
SHFM4 is a "pure" limb malformation (ectrodactyly and syndactyly) 
condition, thus without orofacial clefting or ectodermal dysplasia. It is 
caused by several mutations, which are dispersed throughout the p63 
gene. Possibly, SHFM is caused by altered protein degradation, even 
though different degradation routes are involved (70).  
A non-syndromic orofacial clefting type was also linked to p63 
gene, R313G is the first mutation discovered (84).  
Several examples show that the same mutation can lead to different 
clinical conditions. The possible explanation is the influence of cis-
acting polymorphisms and/or the effects of modifier genes. The 
phenotypic variation between the p63-linked diseases is large, 
furthermore the phenotypic variation within one disease is also 
considerable. It is clear that variability within families may be 
ascribed to a combination of modifier genes, and stochastic processes 
(70 - Fig. 6). 
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Figure 6: p63 and its mutations. Pathogenic p63 mutations cause at 
least five different syndromes and two non-syndromic conditions. 
Mutations causing different diseases are illustrated in different 
colours. EEC hotspot mutations are clustered in DNA binding domain, 
and RHS and AEC syndrome mutations in SAM and PS domains. 
Several mutations, such as R280, R313, I510, S541 and 1850 Del A, 
can have a variable clinical outcome, probably due to genetic 
background effects. The black asterisks illustrate sites needed for 
upiquitination (K193, K194 and PY) and the white asterisk represents 
a sumoylation site (fKXD/E). TA= Transactivation domain; Iso= 
oligomerization domain; SAM= Steril alpha Motif; TID= Post-SAM 
domain. (Adapted from Rinne et al., p63-Associated Disorders, Cell 
Cycle, 2007) 
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1.6 AEC syndrome 
 
About 10% of p63-linked patients have AEC. This syndrome,  
also known as Hay–Wells syndrome, was first reported by Hay and 
Wells in 1976 (85). It is a rare autosomal dominant disorder 
characterized by congenital ectodermal dysplasia, including alopecia, 
scalp infections, dystrophic nails, hypodontia, ankyloblepharon and 
cleft lip and/or cleft palate (Fig. 7A-C). 
Skin lesions are a distinctive signs of AEC syndrome. Adult patients 
can be affected by palmoplantar hyperkeratosis and erosive 
palmoplantar keratoderma with bleeding after extensive walking. The 
biological mechanisms underlying the skin erosions remain unveiled, 
and treatment is limited to gentle wound care and antibiotic treatment 
to prevent or cure infections. Healing is slow and recurrent breakdown 
is typical. 
AEC syndrome causative mutations mainly fall in the C-terminus of 
p63 protein and include twenty-five missense and only two frameshift 
mutations in the SAM domain, whilst in the PS domain predominate 
the frameshift mutations that extend p63 protein. Recently, novel AEC 
causative mutations have been identified that result in translation re-
initiation downstream of the non-canonical transactivation domain in 
the ΔN-specific isoforms, leading to expression of truncated ΔNp63 
protein with dominant negative effects (86).  
The mutations best characterized involve the SAM domain and can be 
separated in two different group. The first subgroup contains those 
mutations that affect amino acids that are predicted to be buried inside 
the protein and have a small solvent accessible surface. The second 
subgroup contains all other amino acids that have a larger solvent 
accessible surface. Mutation of the first subgroup of amino acids is 
likely to affect the overall structure and stability of the protein by 
altering the packing of the helices (I549T, F552S, L553F, L553V, 
C561G, C561W, F565L, I576T, L584P and I597T). In contrast, the 
second subgroup of mutations is not predicted to cause gross 
conformational changes, but are clustered in a small region around 
helix 3, which could indicate that this region is involved in binding of 
the SAM domain to its interaction partner (G557V, G569V, T572P, 
Q575L, S580F, S580P, S580Y, D583C, D583Y, P590L, F593S, 
R594P, G600V and G600D). 
INTRODUCTION 
19 
 
To analyse the effect of these mutations, p63 SAM domain 
containing some of the point mutations above were cloned and 
expressed. The expression of point mutations found in the AEC 
syndrome varied significantly. The wild-type protein and the mutants 
L553V (L514V) and C561W were found to be over-expressed in the 
soluble fraction. In contrast, mutants L553F (L514F), C561G, G569V, 
Q575L and I576T were present only as inclusion bodies, but could be 
refolded easily during purification. The mutants G569V, Q575L and 
I576T partially aggregated at the gel filtration stage but sufficient 
material was purified to allow analysis. Compared with the wild-type, 
mutations L514F, C561G, C561W, G569V, Q575 and I576T are all 
significantly destabilized. A possible explanation for the instability of 
each of these point mutations was obtained by looking at the structural 
features of the wild-type protein. Mutation L514F, which is close to 
F552, would probably cause a severe steric clash between the two 
phenylalanine rings and result in overcrowding in the hydrophobic 
core. The tryptophan ring in C561W would possible result in a steric 
clash with the aromatic ring of F593. The instability of C561G is most 
probably caused by the formation of a hydrophobic cavity resulting 
from the loss of a bulky thiol group. The cavity created would 
potentially cause some rearrangement of the hydrophobic core and the 
associated instability. Introduction of a polar residue into the 
hydrophobic core, as happens with mutation I576T, would potentially 
lower the stability of the domain. Mutation G569V may cause 
instability due to the residues in the loops adopting a more 
unfavorable conformation. Mutation Q575L occurs in a solvent-
exposed position and the side-chain carbonyl of Q575 forms a 
hydrogen bond with the main-chain amides of both T571 and T572. 
The side-chain hydroxyl of T572 forms an N-cap hydrogen bond with 
the main-chain amide of Q575 and thus a mutation to proline would 
abolish the potential to form this hydrogen bond. The location of the 
L514V mutation in the core of the domain precludes this being a 
functional mutation and hence the mutation also appears to be 
structural, possibly by creating a small hydrophobic cavity in the 
hydrophobic core. All the mutants are partially denatured or unfolded 
even under non-denaturing conditions. As such any attempt to 
crystallize the domains would be almost impossible (55). Mutations 
I549T and I597T would also introduce a polar residue into the 
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hydrophobic core, and presumably these mutants would be 
destabilized in a similar manner to mutation I576T. Mutations F552S 
and F565L would both result in the loss of a large aromatic residue 
from the hydrophobic core. Mutation G557V may cause instability 
due to the residues in the loops adopting a more unfavorable 
conformation in a similar manner to that observed for mutation 
G569V. Mutations S580F, S580P and S580Y would all result in the 
loss of the N-cap hydrogen bond from the main-chain amide of D583 
to the side-chain hydroxyl of S580, whilst mutations D583C and 
D583Y would disrupt a hydrogen bond from the main-chain amide of 
S580 to the side-chain carbonyl oxygen of D583. Mutation R594P 
would disrupt a standard hydrogen bond in helix 5. Mutations G600V 
and G600D would probably result in a steric clash between -helix 5 
and L556. Finally, the in-frame 3 bp insert (573–574 inserting TTC) 
encoding an additional phenylalanine residue would be expected to be 
destabilizing as it probably disrupts the packing of the 3
10
-helix to the 
rest of the protein. Of all the mutations only P590L and F593S could 
not easily be explained as mutations that would either disrupt the 
hydrophobic core or result in a loss of a stabilizing hydrogen bond or 
salt bridge. Indeed F593 is a solvent exposed aromatic residue and a 
mutation to a polar residue might even be expected to increase 
stability. Two mutations that appear not to be structural mutations, 
P590L and F593S, are close in sequence to two of the highly 
conserved hydrophilic residues (K588 and Q592) and may indicate 
that this interface plays some role in domain function (55- Fig. 6D).  
Nothing is known about the mutations in the PS domain. Several 
explanations for the surprising absence of missense mutations in the 
core of the PS exist. First, such mutations could be lethal. Second, a 
syndrome would arise only if the mutations would create either a 
dominant-negative or a gain-of-function effect. If the main effect of 
mutations in the PS is a loss of the dominant-negative behavior toward 
other transcriptionally active forms, expression of the second, non-
mutated allele might be enough to sustain the biological function of 
Np63 during development and maintenance of epithelial tissue 
(58). 
About the molecular mechanisms of action of these mutants little is 
known: generally the mutants are more stable than the wild-type 
protein and have a reduced transactivation capability (87). 
INTRODUCTION 
21 
 
To study the functional activity of mutant p63 in AEC syndrome a 
first knock-in mouse model (p63
+/L514F
) was previously generated in 
our laboratory (88).  
This model carries a phenylalanine substitution in position 514 
(L514F) and closely resembles the human disease (88, 89). This 
mutation falls in the first helix of the SAM domain and disrupts the 
folding of the protein. Among the AEC causative mutations we 
decided to focus our attention on L514 amino acids for three reasons: 
first of all, this amino acid is mutated in three different amino acids 
(phenylalanine, valine or serine); this mutation affects an amino acid 
that is predicted to be buried inside the protein and has a small solvent 
accessible surface, so any mutation in this region is likely to affect the 
overall structure and stability of the protein by altering the packing of 
the helices, and moreover the substitution of a leucine with a 
phenylalanine probably cause a severe steric clash between two 
phenylalanine rings that are located close to each other (70, 46). 
p63
+/L514F
 mouse model is characterized by hypoplastic and fragile 
skin, ectodermal dysplasia and cleft palate. Ferone et al.,2010, found 
that epidermal hypoplasia and cleft palate are associated with a 
transient reduction in epithelial cell proliferation during development. 
These defects closely resemble those observed in the Fgfr2b-/- mice 
(90-94). Since p63 transcriptionally controls the Fibroblast growth 
factor  receptors Fgfr2 and Fgfr3 and their expression, they found that 
impaired FGF signaling downstream of p63 is likely an important 
determinant of reduced ectodermal cell proliferation and defective 
self-renewing compartment in AEC syndrome. 
Unfortunately, a neonatal lethality due to cleft palate prevented the 
generation of a mouse line and the studying of the adult phenotype 
(88).  
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Figure 7: AEC phenotype and mutations. (A) A neonate with skin 
erytherma, erosions and cleft lip/palate. (B) A newborn with partial 
fusion of the eyelids(ankyloblepharon). (C) An 18-month-old child 
with extensive erosive scalp dermatitis and alopecia. (Adapted from 
McGrath et al., Hay-Wells syndrome is caused by heterozygous 
missense mutations in the SAM domain of p63, HMG, 2001). (D) 
Ribbon representation of the p63 SAM domain showing the position 
of mutations that are associated with AEC syndrome. (Adapted from 
Sathyamurthy et al., Structural basis of p63 SAM domain mutants 
involved in AEC syndrome, FEBS, 2011) 
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2. MATERIALS AND METHODS 
2.1 Constructs and cell culures 
AEC mutants were obtained using QuikChange site-directed 
mutagenesis (Stratagene) starting from pCMV2-FLAG mNp63All 
the constructs were achieved for PCR. To obtain E570fsX94 and 
N620fsX44, the mutagenesis to delete an aminoacid has been made 
after cloning in pCMV2-FLAG plasmid (Sigma) the N-terminal 
portion of human p63 from pcDNA3 plasmid (Not I-Nco I) together 
with a C-terminal portion of human p63 from cDNA of NHEK cells 
(Nco I-Bgl II). p63SAM is obtained cloning the N-terminal (Not I-
Sac II) and C-terminal (Sac II-Xba I) region of p63 without the 
portion corresponding to SAM domain without changing any 
aminoacid. Finally to obtain GFP N-terminal taggedNp63, p63 
was removed from pCMV2-FLAG plasmid and inserted in pEGFP-1 
using Bgl II. 
HEK293 and COS7 cells were coltured in Dulbecco Modified Eagle 
Medium (Sigma) with 10% of Fetal Bovine Serum (FBS) and 2mM of 
Glutammine and incubated at 37°C, 5% CO2. 
Primary mouse keratinocytes were isolated from skin of 2-day-old 
mice. They were placed in petri dishes with ice and inserted in an ice 
bucket. After 30-45’ mice were washed twice with 70% ethanol and 
twice with water to remove ethanol completely. Using sterile 
techniques, mice tails and limbs were amputated with sterile surgical 
scissors. The skin was carefully separated from the rest of the viscera 
and flattened in a empty 150mm petri dish with the dermis facing 
down; 15 ml of Dispase solution (0.5mg Dispase-GIBCO, Na-
bicarbonate 0.75%, Hepes 10mM, Antibiotic-Antimycotic in PBS) 
were added to each petri dish and incubated o/n at 4 °C. Next day 
epidermis was separated from the dermis and placed in a 100mm Petri 
dish in 2ml (for each epidermis) of 0.125% trypsin-2.5mM EDTA. 
Epidermis was minced with tweezers and scissors until is reduced in 
very small fragments and placed at 37°C for 5-8 minutes. Then trypsin 
is inactivated with DMEM+10% FBS and filtered using cell strainers 
in order to remove the floating particles. Cells were placed into the 
centrifuge for 5 minutes at 1000 rpm; then were plated on collagen 
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coated plates and incubated at 34°C, 8% CO2 in a Low Ca
++
 Medium 
(LCM) with the addition of 4% Chelex serum and EGF. 
 
Oligonucleotide primers for mutagenesis and cloning: 
 
E639X mutagenesi 
CAGCGCATCAAAGAGTAGGGGGAGTGAGCC 
GGCTCACTCCCCCTACTCTTTGATGCGCTG 
 
Q634X mutagenesi 
CGCCGCAATAAGCAATAGCGCATCAAAGAGGAG 
CTCCTCTTTGATGCGCTATTGCTTATTGCGGCG 
 
E570fsX94 and N620fsX44 cloning 
CCCGGCGGCCGCGTTGTACCTGGAAAACAATGCCC 
AGATCATCCATGGAGTAATGCTC 
GAGCATTACTCCATGGATGATCT 
GCGGAGATCTTCCCCTAAGAAATCAGACAAGAGG 
 
E570fsX94 mutagenesi 
CCGGCAGCTCCACGATTCTCCTCCCCTTCT 
AGAAGGGGAGGAGAATCGTGGAGCTGCCGG 
 
N620fsX44 mutagenesi 
CCCCGAGATGAGTGGATGACTTCAACTTTGACATGG 
CCATGTCAAAGTTGAAGTCATCCACTCATCTCGGGG 
 
p63SAM 
AAGCTTGCGGCCGCGTTGTACCTGGAAAACAATGCC 
AAGCTTCCGCGGGTAGGGCGGTGGTGGGGTGCAG 
ACTTCCGCGGCAGCTGCACACGACTTCTCCTC 
CCTCTAGATCATTCTCCTTCCTCTTTGATACGCTG 
 
GFP-Np63
ACTTAGATCTTTGTACCTGGAAAACAATGCC 
ACTTAGATCTTCATTCTCCTTCCTCTTTGATACG 
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2.2 Luciferase reporter assay (luc assay) 
 
Subconfluent HEK293 cells in 12-well dishes were transfected 
using Lipofectamin 2000 (Invitrogen) at a 1:3 ratio between the 
reporter plasmid (containing the firefly luciferase gene under the 
control of K14 promoter) and the expression vectors encoding for 
wild-type and mutated Np63. 5 ng of Renilla Luciferase Vector 
(pRL-CMV; Promega) was co-transfected, as a control of transfection 
efficiency. At 24 h after transfection, cells were washed twice with 
PBS and luciferase activities of cellular extracts were measured, by 
using a Dual Luciferase Reporter Assay System (Promega); light 
emission was measured using a luminometer. Efficiency of 
transfection was normalised using Renilla luciferase activity. 
 
2.3 Western Blot (WB) 
 
Cells were lysed in sample buffer (10% glycerol, 0.01 % 
Bromophenol Blue, 0.0625 M Tris-HCl pH 6.8, 3 % SDS, 5 % 
ßmercaptoethanol). Extracts were run on SDS-PAGE gels, transfer on 
Immobilon-P transfer membranes (Millipore), probed with the 
indicated antibodies and detected by chemiluminescence (ECL, GE 
Healthcare Life Sciences). The following primary antibodies were 
used for immunoblotting analysis: p63 (4A4, 1:200), actin (1:1000) 
and ERK-1 (1:5000), provided by Santa Cruz Biotechnology. 
 
2.4 Co-Immunoprecipitation (Co-IP) 
 
HEK293 and COS7 were plated on 60mm plates and transfected 
with Lipofectamine 2000 and 4mg of wild-type and mutated FLAG 
and GFP-DNp63a. After 48 hours, cell were washed twice with PBS 
and lysed in 600mL of Busslinger lysis buffer (20mM Tris-HCl 
pH7.9, 120mM KCl, 5mM MgCl2, 0.2mM EDTA pH8.0, 0.2% NP40, 
10% Glycerol) with the addition of protease and phosphatase inhibitor 
and dithiothreitol for 15 minutes on ice. After scraping and discard the 
pellet, the total amount of proteins were measured with Bradford 
protein assay and normalized among different samples. 10mL of anti-
FLAG M2 (50% slurry) conjugated agarose beads (Sigma) were used 
to immunoprecipitate for 2 hours at 4°C. Resin was washed 4-5 times 
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with Busslinger lysis buffer with the addition of dithiothreitol and 
Phenylmethanesulfonyl fluoride and finally resuspended in sample 
buffer at 65°C. Part of total extract and immunoprecipitates were 
analyzed by western blotting.  
 
2.5 Protein Expression and Purification in E. coli and Size 
Exclusion Chromatography (SEC) 
 
Genes for murine TAp63a and Np63 were cloned into 
pMAL-c4X vector (New England Biolabs, NEB). All proteins had an 
additional C-terminal and/or N-terminal His6-tag. Proteins were 
expressed in T7 express competent E. coli cells (NEB) and purified 
using Ni-Sepharose Fast Flow (GE Healthcare) and Amylose resin 
(NEB) according to standard protocols. Proteins were further purified 
by size exclusion chromatography (SEC) using a preparative Superose 
6 column (GE Healthcare) in 10 mM potassium phosphate buffer (pH 
7.6) with 200 mM NaCl. All following experiments were performed in 
this storage buffer if not denoted differently. 
SEC of recombinant proteins expressed in E. coli was performed at 
16° C using a Superose 6 10/300 GL column (GE Healthcare), 
calibrated using Blue Dextran 2000, Thyroglobulin (669 kDa), Ferritin 
(440 kDa), Aldolase (158 kDa), and Ovalbumin (43 kDa) (GE 
Healthcare).  
 
2.6 Chromatin Immunoprecipitation (ChIP) 
 
1 x 10^
6
 mouse keratinocytes and 5 x 10^
6 
HEK293 cells were 
fixed with 1% formaldehyde in growth medium at 37°C for 10 min. 
Extracts were sonicated using BIORUPTOR (Diagenode) to obtain 
DNA fragments ranging from 400 to 800 bp in length. Chromatin was 
immunoprecipitated as in the Upstate protocol 
(http://www.upstate.com). Immunoprecipitation was performed using 
anti-p63 (H-137; Santa Cruz Biotechnology) and anti-ERK-1 (K23; 
Santa Cruz Biotechnology) antibodies as negative control. Real-time 
PCR was performed using the SYBR Green PCR master mix in an 
ABI PRISM 7500 (Applied Biosystems). 
About ChIP in vivo isolate skin from E14.5 embryos were fixed with 
1% formaldehyde, rotated 15 minutes at room temperature and 
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blocked with glycine. The obtained cells pellet was treated as 
described above. 
 
Oligonucleotide primers used for ChIP  
human CST8H (97) 
CGTTCCAAAGCCTAACCTGATCA 
TTTTCCCAAACTCCAACCTG 
 
human Fgfr2Int1 (88) 
CCCCGTGGCCGAAAA 
GAAAGCGCAGGCGAGTTCT 
 
human K14prom/enh  
GGGCCTGTCTGAGGAGATAGG 
AGGCATGTTGAGAGGAATGTGA 
 
mouse CST8H (97) 
CTGCGTGTGCGTTGCATATAA 
CGTCATGTCTCCCTGCCTTC 
 
2.7 Preparation of nuclear extracts and Electrophoretic Mobility 
Shift Assay (EMSA) 
 
To prepare nuclear extracts, cells were scraped from dishes into 
isotonic cold phosphate-buffered saline and collected by 
centrifugation at 1,850 g for 10 minutes. The pellet was resuspended 
in 5 volume of buffer A (10mM HEPES pH 7.9, 1.5mM MgCl2, 10mM 
KCl, 1mM dithiothreitol, and freshly added protease inhibitors). Cells 
were incubated on ice for 10 minutes and centrifuged at 1,850 g for 
10 minutes. The pellet was resuspended in 2 volume of buffer A and 
homogenized using Dounce Homogenizer (10–15 strokes). Nuclei 
were pelleted by centrifuging for 2 minutes at 12,000 g. Nuclei were 
resuspended in 2 volume of high-salt buffer B (20 mM HEPES, 25% 
glycerol, 1.5mM MgCl2, 0.45M NaCl, 0.2mM EDTA, 1mM 
dithiothreitol, and freshly added protease inhibitors) and rotated end 
on end on a Rota-Mixer for 30 minutes at 4°C. Nuclear extracts were 
collected from the supernatant by centrifugation in a microcentrifuge 
at 13,500 g for 30 minutes, flash frozen, and stored at -80°C. 
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For EMSAs, complementary oligonucleotides spanning the regions of 
interest were synthesized (IDT Technologies), annealed, and 2pm of 
double-stranded oligonucleotides was used for radioactive labeling 
with [-
32
P]dCTP. A 1–3 bps 5' overhang was designed at each end to 
allow labeling by fill-in with Klenow polymerase. After labeling, 
probes were purified using G-50 Nick columns (Amersham, 
Piscataway, NJ). Binding reactions were performed at room 
temperature in 20L of DNA-binding buffer (20mM HEPES, pH 7.9, 
75mM KCl, 10% glycerol, 1mM dithiothreitol, and 2.5mM MgCl2) with 
4–6 g of nuclear extracts. One microgram of poly(dA-dT) or 
poly(dI-dC) was added as a nonspecific DNA competitor. For 
supershift assays, antibodies were preincubated with nuclear extracts 
for 20 minutes at room temperature before addition of labeled probe. 
Antibody used in EMSAs was anti-p63 (RR-14). The protein–DNA 
complexes were resolved by gel electrophoresis on 5% non-denaturing 
polyacrylamide gels at room temperature. Gels were dried and 
visualized by autoradiography. 
 
Oligonucleotide primer used for EMSA 
 
K14 enhancer site (101) 
GCAGGGGCTGTTGGGGCCTGTCTGAGGA 
 
2.8 Generation of a conditional AEC mouse model 
 
Neonatal lethality in heterozygous p63+/L514F (88) prevented the 
generation of a mouse line and the studying of the adult phenotype. To 
overcome lethality, we recently generated a conditional knock-in 
model (p63
+/floxL514F
), in which the L514F mutation is inserted in exon 
13 and expressed only in the presence of the Cre recombinase. A 
3xFLAG tag was inserted at the C-terminus of the mutant protein. The 
construct was inserted by recombination in murine embryonic stem 
(ES) cells. A neomycin cassette was inserted to select positive clones 
of ES cells and it can be removed by Flp-mediated recombination.  
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2.9 Mouse genotyping 
 
Conditional knock-in p63
+/L514F,L514F/L514F
, knock-in p63
+/L514F
 
and p63
+/-
 mutant mice were genotyped by PCR using genomic DNA 
isolated from mouse tails. 
 
Oligonucletide primers used for PCR 
 
Conditional knock-in p63
+/L514F,L514F/L514F
  
CAGCGTATCAAAGAGGAAGGAGA 
AGCCAGAATCAGAATCAGGTGAC 
The expected bands were of 250bp for the wild-type mice, 337bp for 
the mutant homozigous mice and both for the heterozigous ones. 
 
knock-in p63
+/L514F 
(88) 
GTCTGACCTCCCGACCCACCTCCT 
GCATGATGAGCAGCCCAACCTTGCT 
GCATGATGAGCAGCCCAACCTTGCA 
The first was the forward primer in common for the amplification of 
wild-type and mutant allele, while the reverse primer differed only at 
3’ for the presence of the point mutation. Genomic DNA from 
p63
+/L514F
 was amplified by both couples of primers, whereas genomic 
DNA from wildtype littermates was amplified only by the oligo 
reverse with the correct base in 3’ first position. 
 
p63
+/- 
(102) 
GTGTTGGCAAGGATTCTGAGACC 
GGAAGACAATAGCAGGCATGCTG 
The wild-type mice had no bands, while for the heterozigous ones the 
band expected was of 450bp.  
 
2.10 Adenovirus infection 
 
Mouse primary keratinocytes were infected after 4-5 days of 
plating, when they reached confluence. Adenovirus carring the GFP or 
the Cre-recombinase (provided by OKAIROS) at MOI 100 were 
diluted in 200L and 1.2mL respectively for 12-well and 60mm 
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dishes of LCM without serum and EGF. After 2 hours of infection, 
supplemented medium was added and left o/n at 34°C. 
 
2.11 RT real time PCR 
 
Total RNA was extracted two and four days after infection from 
primary keratinocytes using TRIzol reagent (Invitrogen). cDNA was 
synthesized using SuperScript Vilo (Invitrogen). Two-step real-time 
reverse transcription RT-PCR was performed using the SYBR Green 
PCR master mix in an ABI PRISM 7500 (Applied Biosystems). 
Levels of the target genes were quantified using specific 
oligonucleotide primers and normalized for Actb (-actin) expression. 
 
Oligonucletide primers used for Real-Time RT-PCR 
 
mouse Actin 
CTAAGGCCAACCGTGAAAAGAT 
GCCTGGATGGCTACGTACATG 
 
mouse Krt5 
CAACGTCAAGAAGCAGTGTGC 
TTGCTCAGCTTCAGCAATGG 
 
mouse Krt14 
ACCACGAGGAGGAAATGGC 
TGACGTCTCCACCCACCTG 
 
mouse Dsc3 
CCACCGTCTCTCACTACATGGA 
TGTCCTGAACTTTCATTATCAGTTTGT 
 
mouse Dsp 
CACCGTCAACGACCAGAACTC 
GATGGTGTTCTGATTCTGATGTCTAGA 
 
mouse IRF6 
CAGCTCTCTCCCCATGACTGA 
CCCATACTCCTTCCCACGATAC 
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mouse Fgfr2 
TGGATCGAATTCTGACTCTCACA 
TTCGAGAGGCTGGGTGAGAT 
 
2.12 Histopathology 
 
E18.5 embryos were dissected, fixed overnight  in 4% 
paraformaldehyde (PFA) and embedded in paraffin using standard 
methods. Sections (7 μm) were deparaffinized and stained with 
Haematoxylin and Eosin (H&E) . The pictures of skin were taken 
using a Zeiss  Axioskop2 plus Microscope.  
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3. RESULTS 
3.1 AEC mutants have an impaired ability to induce p63 target genes 
To explore the mechanism underlying AEC syndrome we tested 
the possibility that AEC mutant proteins may have an impaired ability 
to activate transcription of p63 target genes. For this reason we tested 
a number of p63 mutants characteristic of AEC syndrome in 
transactivation assay in heterologous cells. 
Specifically we analyzed the transcription activation of missense 
mutations involving the SAM domain, L514F, G534V (46), C519R, 
D544Y, and frameshift mutations in the PS domain, E570fsX94 (76) 
and N620fsX44 (70), that extend p63 protein of 94 and 44 amino 
acids respectively. In addition we also tested an EEC mutation, 
R304Q (75), and two SHFM mutations, Q630X (95) and E635X (74). 
A luciferase reporter assay was performed in p63-null HEK293T cells 
as described (94) using the firefly luciferase gene under the control of 
the Krt14 promoter, which modulates the expression of a protein 
physiologically expressed in basal keratinocytes. As reported by Serra 
et al., 2011 (95), the mutation that disrupt the DNA binding domain, 
displayed a reduced activity (here we used R304Q), while the 
mutations causative of SHFM, Q630X and E635X, displayed a 
transcriptional activity similar to wild-type protein, as expected since 
Krt14 is not involved in this pathogenesis. We found that missense 
mutations of SAM domain and frameshift mutations of PS domain 
displayed a very strong reduction of transcriptional activity. 
Interestingly, this reduction was stronger than that observed for the 
DBD mutation (Fig. 8A).  
To further explore the role of the two C-terminal domains of p63 
isoform, that are involved in AEC syndrome, we obtained two 
deletion p63 mutants that lack alternatively SAM (p63SAM) or PS 
(p63PS) domain, and tested their transcriptional activity on Krt14 
promoter. We found that p63SAM had a reduced capability to 
transactivate, whilst p63PS had a stronger activity than the wild-type 
Np63 protein (Fig. 8B).  
These results demonstrate that all AEC causative mutations have an 
impairment to activate the transcription of p63 target genes, moreover 
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lack of the SAM domain also impaired p63 activity while lack of PS 
domain does not.     
 
 
 
Figure 8: AEC p63 mutants and DSAM do not activate 
transcription. (A) Luc assay on Krt14 promoter region in HEK293T 
cells reveals that Np63Q630X and E635X can activate 
transcription but not AEC mutants, L514F, G534V,D544Y, C519R, 
E570fsX94, N620fsX44. EEC mutant R304Q is used as negative 
control of transactivation. The picture is representative of three 
independent experiments. On the right side of picture western blot 
analysis of p63 mutants revealed with anti-p63 4A4 antobodies and 
normalized for -actin. EEC= ectrodactyly, ectodermal dysplasia and 
cleft lip/palate syndrome; AEC= ankyloblepharon-ectodermal defects-
cleft lip/palate syndrome; SHFM= split hand/foot malformation. (B) 
Luc assay on Krt14 promoter region in 293T cells reveals p63SAM, 
but not p63PS, has an impairment in activate transcription. The 
picture is representative of four independent experiments. On the right 
side of picture western blot analysis of p63 deletion mutants revealed 
with anti-p63 4A4 antobodies and normalized for total ERK. DSAM= 
p63SAM; PS= p63PS; CTR= negative control. 
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3.2 AEC mutations do not affect tetramerization 
 
In mouse oocytes TAp63 exists in a closed dimeric 
conformation and phosphorylation triggers the formation of active 
TAp63 tetramers. This switch from dimers to tetramers increases the 
DNA binding affinity of p63 of about 20 fold. In contrast, the most 
abundantly expressed isoform in the skin, Np63forms tetramers, 
since it lacks the TA domain (96). 
Since AEC mutants have lost the ability to transactivate transcription, 
we asked if the reason is the inability to tetramerize with themselves 
and with wild-type proteins. First of all, we performed Co-IP assays 
both in HEK293FT and in COS7 cells. To this purpose, we tagged the 
various p63 protein with either GFP or FLAG, and we transfected 
them in different combination. Western blot analysis of the 
immunoprecipitates displayed that in all different combinations the 
L514F mutant protein is able to bind wild-type protein and itself (Fig. 
9A). 
Co-IP assays were also performed with Np63 proteins lacking the 
SAM and PS domains. FLAG deleted mutants were co-transfected 
with GFP wild-type protein and, as expected, both mutants are able to 
bind wild-type counterpart (Fig. 9B).  
In collaboration with Prof Volker Dötsch (Institute of Biophysical 
Chemistry and Center for Biomolecular Magnetic Resonance, Goethe 
University, Frankfurt 60438, Germany), we performed a size 
exclusion chromatography (SEC) analysis of purified murine L514F 
mutant p63 protein expressed in Escherichia coli. The classification of 
p63 as a dimer or tetramer was based on a calibration of the SEC 
column with compact globular proteins. An enrichment at a SEC 
elution fractions 1.30 ml correspond to an elution of a tetrameric 
protein, while an elution at 1.55 ml correspond to a dimeric protein. 
TAp63L514F, similarly the wild-type, eluted as a dimeric protein, 
while Np63L514F eluted as a tetramer, as its wild-type counterpart 
(96- Fig. 9C).  
These results indicate that L514F p63 mutant is able to associate with 
wild-type Np63 protein and itself, and retains the ability to 
tetramerize. Moreover p63SAM and PS are able to bind wild-type 
Np63 protein, indicating that these two C-terminal domains are not 
involved in homodimerization of Np63. 
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Figure 9: AEC L514F p63 mutant is still competent to 
tetramerization. (A) Co-IP assay with GFP or FLAG tagged wild-
type Np63 and AEC L514F mutant transfected in HEK293FT cells 
in different combination reveals that AEC mutant is able to dimerize 
with wild-type protein and itself. GFP-Np63 and FLAG-
Np63is used as control of Co-IP. Part of total extract and 
immunoprecipitates were analyzed by western blotting. (B) Co-IP 
assay in HEK293FT cells revealed that p63SAM and p63PS are 
able to dimerize with wid-type Np63TOT= total; IP= 
immunoprecipitates; WB= western blot; DSAM= p63SAM; PS= 
p63PS; CTR= negative control. (C)  Bar diagram showing relative 
p63 signal intensities of SEC elution fractions from 1.00 to 1.70 ml of 
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mTAp63, mTAp63L514F and Np63L514F, and western blot of 
SEC elution fraction from 1.05 to 1.70 ml of Np63. The 
enrichment is at 1.55 for mTAp63and mTAp63L514F indicating 
their dimeric elution, and at 1.30 for Np63 and Np63L514F 
indicating their tetrameric elution. m= mouse. 
    
 
3.3 AEC mutant proteins bind DNA less efficiently than wild-type 
p63 
 
To test the hypothesis that AEC mutants may be unable to 
transactivate p63 target genes due to an impaired ability to bind DNA, 
we performed ChIP assays in HEK293FT cells with an anti-p63 
antibodies (H137). We transfected Np63 and L514F p63 mutant 
alone or in combination and analyzed DNA binding to different p63 
genes, such as p63 itself in the C40 (97) enhancer element and Fgfr2 
(88). The DNA binding p63 mutant R304Q was used as negative 
control. In both binding regions we found that L514F p63 mutant had 
a strongly reduced binding to DNA and in presence of the wild-type 
p63 protein the binding was not restored (Fig. 10A).  
So we extended this analysis to others AEC mutants G534V, C519R, 
D544Y, E570fsX94 and N620fsX44. Similar ChIP analysis revealed 
that all mutants had an impaired ability to bind DNA, while the SHFM 
Q630X and E635X did not, suggesting that this is the reason why 
AEC mutants have an impaired transactivation ability.   
To understand if SAM or PS domains are involved in the DNA 
binding, we performed ChIP with p63SAM and p63PS. 
Unexpectedly, but in accordance with the results of transactivation 
activity, p63SAM had an impaired DNA binding, while p63PS did 
not (Fig. 10B). 
To verify the correlation between the transactivation assays performed 
with Krt14 promoter and the results of impaired binding to DNA, we 
also tested the ability of the mutants to bind to Krt14 enhancer (98). 
Similarly to the other tested enhancer, AEC mutants and p63SAM, 
but not the SHFM mutants and p63PS, had a reduced DNA binding 
(Fig. 10C).  
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Figure 10: AEC p63 mutants and SAM have a reduced DNA 
binding ability. (A) ChIP assay of wild-type and L514F Np63 
transfected in HEK293FT alone or in combination on C40 and Fgfr2 
p63 binding sites reveals that L514F p63 mutant has an impairment in 
DNA binding ability, also in combination with wild-type protein. EEC 
mutant R304Q is used as negative control of DNA binding. The 
picture is representative of at least four independent experiments. On 
the right side of picture western blot analysis of p63 mutants revealed 
with anti-p63 4A4 antobodies and normalized for -actin. *=0.01, 
**=0.0007. (B) On the left side, ChIP assay of AEC and SHFM p63 
mutants transfected in HEK293FT cells on C40 binding site reveals 
that AEC p63 mutants have a reduced binding to DNA, while SHFM 
p63 mutants do not. The picture is representative of at least three 
independent experiments. *<0.01. On the right side, ChIP assay 
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performed on C40 binding site reveals that p63SAM, but not 
p63PS, has a reduced DNA binding ability. The picture is 
representative of at least four independent experiments. *=0.005. (C) 
ChIP assays of AEC, SHFM (on left side) and deleted p63 mutants 
(on right side) are performed on Krt14 p63 binding site and reveled 
that AEC p63 mutants and p63SAM have an impairment in binding 
also this region. ab= antibodies; AEC= ankyloblepharon-ectodermal 
defects-cleft lip/palate syndrome; SHFM= split hand/foot 
malformation; DSAM= p63SAM; PS= p63PS; CTR= negative 
control. 
 
 
To confirm these results, in collaboration with Prof. Satrajit Sinha 
(Department of Biochemistry, Center of Excellence in Bioinformatics 
& Life Science, SUNY at Buffalo, NY), we performed an EMSA 
analysis on nuclear extract of HEK293 cells transfected with AEC 
mutants and p63SAM and p63PS. Binding was tested on an 
oligonucleotide corresponding to Krt14 enhancer and was observed 
with the wild-type protein but not the R304Q DNA binding mutant 
used as negative control. Interestingly, L514F, E570fsX94, 
N620fsX44 and p63SAM had a reduced binding and to a lesser 
extent G534V, while not p63PS. To demonstrate the binding 
specificity, we verified the supershift with an anti-p63 antibodies that 
recognizes the N-specific region (RR-14) (Fig. 11). 
These results indicate that AEC mutants bind DNA less efficiently 
than wild-type protein. Reduced binding was confirmed on various 
p63 DNA binding region with different assays. SAM domain seems to 
be required for binding, while PS domain do not, indeed only the lack 
of the first impaired this ability.  
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Figure 11: AEC p63 mutants and p63DSAM fail to bind an 
oligonucleotide corresponding to Krt14 enhancer. EMSA assay of 
nuclear extract of HEK293 cells transfected with Np63, AEC p63 
mutants, p63SAM and p63PS reveals that L514F, E570fsX94, 
N620fsX44 and p63SAM have a reduced binding and to a lesser 
extend G534V, while not p63PS. In the second half of gel same 
extracts are incubated with an anti-p63 antibodies that recognizes the 
N-specific region (RR-14) and the specificity of binding is 
demonstrated by supershift. Black arrows indicate shift (left) and 
supershift (right). ns: non specific. 
 
 
3.4 Impaired gene expression of several target genes in AEC mutant 
heterozygous and homozygous keratinocytes 
Since HEK293 cells do not express p63, to test the physiological 
significance of our findings we analyzed the effect of an endogenous 
L514F p63 mutant in primary keratinocytes. 
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To this aim we took advantage of a conditional knock-in mouse model 
(p63
+/floxL514F
) recently generated in our laboratory, in which the 
L514F mutation is expressed only in the presence of the Cre 
recombinase. A 3xFLAG tag was cloned at the C-terminus of the 
mutant gene. The construct was inserted by recombination in murine 
embryonic stem (ES) cells (Fig.12A).  
Primary keratinocytes obtained from homozygous and heterozygous 
mice for the mutation were infected with adenovirus carring a Cre-
recombinase to activate the mutation. Adenovirus carring a GFP 
protein was used as control. At two (data not shown) and four days 
after infection we performed ChIP assays in primary keratinocytes 
with two different anti-p63 antibody, H137, that recognizes all p63 
isoforms and H129, that recognizes only the alpha-isoform involved in 
AEC syndrome. AEC mutant was significantly impaired in DNA 
binding by itself and, to a lesser extent, in the presence of the wild-
type protein, in accordance with the data obtained in heterologous 
system (Fig. 12B). 
To assess the effects of this reduced DNA binding, RNAs from 
keratinocytes were collected two and four days after infection to 
evaluate changes in gene expression both soon after expression of 
mutated proteins and after few days. Different known p63 target genes 
were measured, such as Fgfr2 (88), Krt14 and Krt5 (99), Irf6 (100), 
Dsc3 and Dsp (89). In homozygous keratinocytes p63
L514F/L514F 
we 
observed a strongly decreased expression of all the analyzed genes 
both after two and after four days. In heterozygous keratinocytes 
p63
+/L514F 
the most affected genes was IRF6 and Fgfr2, in which a 
strongly reduction in their expression was evident after two and four 
days of infection (Fig. 12C).
 
These results indicate that even in its natural context AEC mutant has 
a reduced DNA binding not only in homozygous keratinocytes but 
also in heterozygous ones and that the consequence of this impairment 
is the reduced expression of different p63 target genes. 
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Figure 12: Reduced expression levels of several target genes in 
AEC mutant keratinocytes. (A) Gene targeting strategy used to 
generate the p63
+/floxL514F 
inducible knock-in mice. The L514F 
mutation is indicated with *. Blue and white triangles indicate Lox 
and Flip sites respectively. A 3xFLAG tag was cloned at the C-
terminus of the mutant gene. (B) ChIP assay performed on C40 four 
days after infection with two different anti-p63 antibodies, H137, that 
recognizes all p63 isoforms and H129, that recognizes only the alpha-
isoform, reveals that both in heterozygous and mainly in homozygous 
keratinocytes DNA binding is reduced. IgG ab is used as negative 
control. ab= antibodies; L= L514F. (C) After controlling the right 
expression of p63 wild-type and L514F in keratinocytes treated with 
adenoGFP and adenoCRE (left side), RT real-time PCR of collected 
RNA from heterozygous and homozygous keratinocytes reveals 
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impaired gene expression of Krt14, Krt5, Dsc3, Dsp, IRF6 and Fgfr2 
at two and four days after infection.   
 
 
3.5 p63
-/L514F
 mice have a perinatal lethal phenotype closely 
resembling the p63 null ones 
Mice heterozygous for p63 (p63
+/-
) are indistinguishable from 
wild-type littermates because one copy of all p63 isoforms is 
sufficient to maintain the ectodermal development in mice. 
To better understand the mechanism of action of L514F p63 protein, 
we mated p63
+/-
 mice with the knock-in p63
+/L514F
 ones to obtain p63
-
/L514F
 mice. ChIP assay in E14.5 embryo skin of p63
+/L514F
, p63
-/L514F
 
and wild-type using anti-p63 antibody (H137) revealed that L514F 
mutant p63 had an impairment in binding DNA on p63 enhancer 
element (Fig. 13A).  
Sagittal views of E18.5 p63
-/L514F
 mice showed an evident phenotype 
with cleft palate, craniofacial abnormalities and forelimbs and 
hindlimbs defects. p63
-/L514F
 and p63
-/-
 embryos had no eyelids, 
whisker pads, skin and related appendages, which are present on the 
wild-type control. p63
-/-
 embryos lacks both forelimbs and hindlimbs 
as already reported by Mills et al., 1999 and Yang et al., 1999 (9, 10). 
In the p63
-/L514F
 embryos hindlimbs were absent similarly to the 
knock-out, whereas  forelimbs were more developed but still abnormal 
(Fig. 13B). 
To analyze the effects of the AEC mutation on the skin phenotype, we 
performed an hematoxilin and eosin staining on skin sections. While 
p63
+/L514F
 epidermis was hypoplastic as already described by Ferone et 
al., 2011 (68), in p63
-/L514F
 the epidermal layers were disorganized, 
discontinuous and often detached from the dermis, similarly to the 
p63
-/-
 (Fig. 13C). 
These findings indicate that at least an intact  isoform is essential for 
epidermal, limbs and craniofacial development and that L514F 
mutation affects all these functions due to an impairment in DNA 
binding on p63 target genes.  
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Figure 13:  p63
-/L514F
 mice closely resembling the p63 null ones. 
(A) ChIP assay performed on C40 p63 binding site of E14.5 skin 
embryos  with anti-p63 antibodies, H137, reveals that in knock-
out/L514F embryos DNA binding is reduced. ab= antibodies; L= 
L514F. *=0.0013. (B) Sagittal views of E18.5 p63
+/+
, p63
+/L514F
, p63
-
/L514F
, p63
-/-
 mice showed for p63
-/L514F
 (red square) an evident 
phenotype with cleft palate, craniofacial abnormalities and forelimbs 
and hindlimbs defects. (C) H&E staining on skin sections of p63
+/+
, 
p63
+/L514F
, p63
-/L514F
, p63
-/-
 mice showed p63
+/L514F
 hypoplastic 
epidermis  while in p63
-/L514F
 the epidermal layers were disorganized, 
discontinuous and often detached from the dermis, similarly to the 
p63
-/-
. 
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3. DISCUSSION 
p63 gene is a transcription factor, member of p53 gene family, 
crucial for the development and maintenance of squamous epithelia. It 
is specifically expressed in the basal layers of stratified epithelial 
tissues in which it is mainly involved in maintaining cell proliferation 
and cell adhesion (13, 11, 32, 33). Its expression decrease upon 
keratinocyte differentiation, suggesting that p63, through the balance 
of its isoforms, is required for initiating epithelial stratification (11, 
28, 33) and concurrently it inhibits differentiation (19, 28). 
Np63α is the most abundant isoform in the skin (16) and one of the 
first genes to be specifically expressed in the surface ectoderm at 
E7.5-E8. It continues to be expressed during skin development and in 
the basal proliferative layer in postnatal life (11, 25, 16). 
This isoform contains two additional domains not present in p53 and 
likely responsible for Np63α functions p53-unlike (23, 36): a SAM 
domain and a PS domain, whose functions in the context of p63 
remain still unknown. Very few interactors of p63 that bind the 
protein interaction module SAM are known, such as ABBP1 and 
Scaf4/rA4 (56) or Cables1 (57). About PS domain, it shows no 
homology to any known sequence and it seems to be involved in 
inhibition of transactivation ability by binding and masking the TA 
domain of p63 (58). Its function in Np63α, in which lacks TA 
domain, remains completely unknown. 
The study of these domains is of great interest as they are involved in 
an autosomal dominant disorder known as AEC syndrome.  
AEC syndrome belongs to the ectodermal dysplasia pathology and it 
is characterize by ectodermal dysplasia, ankyloblepharon and cleft lip 
and/or cleft palate. It is caused by mutations that fall in the SAM or 
PS domains, in the first case they are mainly missense mutations, 
while in the PS domain frameshift mutations that elongate p63 protein 
predominate. 
In this work we investigate the functional role of these two domains 
and their involvement in AEC pathogenesis, starting from the study of 
different mutations causative of this syndrome and analyzing the 
consequence of lack of SAM or PS domains in Np63's functions. 
We found that missense mutations of SAM domain and frameshift 
mutations of PS domain impair transcriptional activation of Krt14, a 
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direct target gene of p63 physiologically expressed in basal 
keratinocytes (98), in luciferase assays performed in heterologous 
system. Moreover we observed a different behavior for p63 that lacks 
SAM or PS domain, this demonstrate that functions are not redundant 
for these two domains, indeed p63SAM have a reduced capability to 
transactivate transcription, while p63PS have a stronger activity than 
the wild-type Np63 protein.   
A possible explanation for the different behavior of SAM and PS 
domains is that the first is necessary for transactivation activity of 
Np63 protein, indeed point mutations in this domain are sufficient 
to strongly reduced this ability. PS domain does not seem to be 
implicated in transactivation, indeed only large rearrangements, such 
as frameshift mutations that extend p63 protein, but not the deletion of 
the whole domain, are responsible for the reduction of activity. The 
different response to the transactivation assays of frameshift mutations 
and total deletion of PS domain suggest that elongation of p63 protein 
could disturb the role of near domains.  
First we ensured that L514F p63 mutant retains the ability to 
tetramerize, condition required for DNA binding, and that  
Np63SAM and Np63PS are able to bind wild-type Np63 
protein, indicating that these two C-terminal domains are not involved 
in homodimerization of p63. Then we investigated the ability of AEC 
mutants and p63SAM and p63PS to bind DNA with ChIP assays in 
HEK293FT cells. This capacity was tested on different p63 binding 
sites, such as C40, Fgfr2 and Krt14, and indicate that AEC mutants 
bind DNA less efficiently than wild-type protein. Moreover the co-
expression of wild-type and L514F mutant does not restore the 
binding to DNA, suggesting that AEC mutant sequesters the wild-type 
protein in a still possible tetramers not working, acting as a dominant 
negative. Similar experiments of ChIP were performed for the two 
deletion mutants and demonstrated that SAM domain seems to be 
required for binding, while the PS one does not, indeed only the lack 
of the first impaired DNA binding, in accordance with results of 
transactivation assays. 
To test the physiological significance of our findings we analyzed the 
effect of an endogenous L514F p63 mutant in primary keratinocytes, 
evaluating DNA binding and measuring expression levels of p63 
target genes. The results indicated that even in its natural context AEC 
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mutant has reduced DNA binding in both homozygous and 
heterozygous keratinocytes and that the consequence of this 
impairment is the decresead expression levels of different p63 target 
genes, such as IRF6, Fgfr2, Dsc3, Dsp, Krt5 and Krt14. The reduced 
binding to DNA also in heterozigous keratinocytes confirms that 
L514F p63 mutant protein acts as a dominant negative. This reduction 
in DNA binding could be explained with an intrinsic incompetence of 
the mutated protein to bind DNA or to recruit some co-factors 
necessary for the binding.  
In the context of primary keratinocytes, the presence of two copies of 
all other p63 isoforms doesn't restore the transactivation ability of p63 
impaired by AEC mutant protein, suggesting that wild-type  isoform 
is required for these functions. This observation was even clearer 
when we analyzed the effect of L514F p63 mutation in p63 
heterozygous mice with one copy of p63 isoforms. While p63
+/-
 mice 
were indistinguishable from wild-type littermates because one copy of 
all p63 isoforms is sufficient to sustain the ectodermal development, 
p63
-/L514F
 mice showed an evident phenotype with cleft palate, 
craniofacial abnormalities and forelimbs and hindlimbs defects, 
underlying the necessity of at least one copy of wild-type  isoforms.     
Moreover in spite of an hypoplastic epidermis observed in p63
+/L514F
 
mice (68), in p63
-/L514F
 the epidermal layers were disorganized, 
discontinuous and often detached from the dermis, similarly to the 
p63
-/-
. At molecular level ChIP assays in E14.5 embryos p63
-/L514F
 
skin confirmed a L514F p63 mutant impairment in DNA binding. 
These findings indicate that at least one dose of intact  isoforms is 
essential for epidermal, limbs and craniofacial development, that  
and  isoforms can not rescue epidermal phenotype and that L514F 
mutation strongly affects all these phenotypes.  
In this work we shed light on the mechanisms underlying AEC 
syndrome showing for the first time that all analyzed AEC mutants 
have an impairment in DNA binding causing a consequent reduction 
in the expression levels of different p63 target genes. 
Moreover we demonstrate the different involvement in transactivation 
and DNA binding ability of two C-terminal domains of p63isoform. 
In particular SAM domain seems to be required for these p63 
functions, indeed its deletion, in spite of an intact DNA binding 
domain, results in a strong reduction in activating transcription of 
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Krt14 in luciferase assays and in an impaired DNA binding ability on 
all sites tested. This is not true for PS domain, in which the analyzed 
AEC causative frameshift mutations are responsible for described 
impairment but the deletion of whole domain does not, indicating that 
this domain is not involved in these functions.   
 
Fig. 14: Proposed model of mechanisms underlying AEC 
syndrome. AEC mutants have an impaired ability to bind DNA. The 
result of reduced binding is severe phenotype in mice as well as in 
humans due to decreased levels of p63 target genes. 
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Abstract: 
 
Epidermal structure is damaged by exposure to ultraviolet (UV) light but the molecular 
mechanisms governing structural repair are largely unknown. UVB (290-320 nm wavelengths) 
exposure prior to induction of differentiation reduced expression of differentiation-associated 
proteins, including Desmoglein 1 (Dsg1), Desmocollin 1 (Dsc1) and Keratins 1 and 10 (K1/K10) 
in a dose-dependent manner in normal human epidermal keratinocytes (NHEKs). The UVB-
induced reduction in both Dsg1 transcript and protein was associated with reduced binding of the 
p63 transcription factor to previously unreported enhancer regulatory regions of the Dsg1 gene. 
Since Dsg1 promotes epidermal differentiation in addition to participating in cell-cell adhesion, 
the role of Dsg1 in aiding differentiation after UVB damage was tested. Compared to controls, 
depleting Dsg1 via shRNA resulted in further reduction of Dsc1 and K1/K10 expression in 
monolayer NHEK cultures and in abnormal epidermal architecture in organotypic skin models 
recovering from UVB exposure. Ectopic expression of Dsg1 in keratinocyte monolayers rescued 
the UVB-induced differentiation defect. Treatment of UVB-exposed monolayer or organotypic 
cultures with Trichostatin A, a histone deacetylase inhibitor, partially restored differentiation 
marker expression, suggesting a potential therapeutic strategy for reversing UV-induced 
impairment of epidermal differentiation after acute sun exposure.
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Introduction: 
 
The epidermis is a multilayered structure that provides a barrier against environmental 
insults. However, all epidermal layers can be penetrated by ultraviolet (UV) light resulting in 
potentially mutagenic DNA damage (Courdavault et al., 2005; Pfeifer and Besaratinia, 2012) and 
changes in epidermal structure. UV-induced histological changes include hyperplasia, 
appearance of “sunburn cells” (pyknotic nuclei, eosinophilic cytoplasm, lacking expression of 
differentiation markers), disappearance of the granular layer, parakeratosis (aberrant persistence 
of nuclei in the stratum corneum), and acanthosis (thickening) and hyperkeratinization of the 
stratum corneum, all indicative of abnormal differentiation and altered barrier function (Bayerl et 
al., 1995; Bernerd and Asselineau, 1997; Lavker et al., 1995; Lorincz, 1960; Matsumura and 
Ananthaswamy, 2004; Rosario et al., 1979). The molecular pathways leading to repair of the 
epidermal structure and restoration of normal differentiation after UV exposure remain largely 
unknown.  
 
Normal epidermal differentiation and barrier formation require the carefully 
choreographed expression of cytoskeletal, cell adhesion, and cell envelope proteins specific for 
each cell layer. UV exposure impairs the expression of later differentiation markers such as 
involucrin, loricrin, filaggrin, and transglutaminase, corresponding with the histologically 
observed reduction in the granular layer and disturbance of the stratum corneum (Bayerl et al., 
1995; Bernerd and Asselineau, 1997; Del Bino et al., 2004; Gambichler et al., 2008; Kwon et al., 
2008; Lee et al., 2005; Lee et al., 2002; Li et al., 2001; Rundhaug et al., 2005; Sesto et al., 2002; 
van der Vleuten et al., 1996). UV exposure also disrupts the epidermal permeability barrier and 
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cell-cell communication by altering the arrangement of the tight junction proteins occludin and 
claudins-1 and -4 (Robert et al., 1999; Yuki et al., 2011), the lipid composition in upper 
epidermal layers (Holleran et al., 1997), and the localization of connexin 43 (Cx43) (Bellei et al., 
2008; Provost et al., 2003).  
 
Expression of both classic and desmosomal cadherins is also altered by UV exposure 
(Dusek et al., 2006; Gambichler et al., 2008; Hung et al., 2006; Li et al., 2001; Murakami et al., 
2001; Rundhaug et al., 2005; Sesto et al., 2002). Of particular interest is Desmoglein 1 (Dsg1), 
one of several desmosomal cadherins that complex with armadillo proteins (i.e. Plakoglobin – Pg 
and Plakophilins – Pkps), and plakins (e.g. Desmoplakin – Dp) to anchor keratin intermediate 
filaments to the cell membrane. Dsg1 is first expressed as keratinocytes transit from the basal to 
the immediate suprabasal layer and becomes increasingly concentrated in desmosomes of the 
granular layer where it plays a critical role in intercellular adhesion (Green and Simpson, 2007). 
The Dsg1 cytoplasmic domain also promotes epidermal differentiation and proper epidermal 
morphogenesis (Getsios et al., 2009). Knocking down Dsg1 results in reduction of the granular 
layer in epidermal models and reduced expression of differentiation markers desmocollin 1 
(Dsc1), loricrin, filaggrin, and keratin 10 (K10). Dsg1 mRNA transcripts have been reported as 
downregulated after UV exposure, one of many transcriptional changes that occur in UV-
exposed keratinocytes (Murakami et al., 2001; Rundhaug et al., 2005).  Further, exposure of well 
differentiated keratinocytes to UVC wavelengths (below 290 nm which do not reach the earth’s 
surface) leads to cellular redistribution and caspase-dependent cleavage of Dsg1 protein (Dusek 
et al., 2006). However, no study has yet examined the impacts of UVB wavelengths (290-320 
nm that impact human skin) on the expression or function of Dsg1 protein in the epidermis. 
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Since Dsg1 promotes epidermal differentiation (Getsios et al., 2009), we examined the 
role of Dsg1 in governing recovery of keratinocyte differentiation following UVB exposure. 
UVB exposure resulted in reduced expression of Dsg1, Dsc1, K10, and K1 expression in a dose-
dependent manner but did not reduce the predominantly basally-expressed Dsg3 protein or the 
adherens junction cadherin E-cadherin (Ecad). UVB-induced reduction of Dsg1 mRNA and 
protein was associated with decreased binding of the transcription factor p63 to previously 
unreported enhancer regulatory regions of the Dsg1 gene. Dsg1 silencing resulted in further 
reduction in Dsc1, K1, and K10 protein expression and in abnormal epidermal architecture after 
UVB exposure while ectopic Dsg1 expression led to recovery of the differentiation program.  
These findings establish Dsg1 is a specific regulator of the epidermal recovery process after 
assault by UVB light. Dsg1 may therefore be a therapeutic target for restoration of epidermal 
differentiation after sun exposure. Indeed, the histone deacetylase (HDAC) inhibitor Trichostatin 
A (TSA), which was previously shown to increase expression of desmosomal cadherins 
(Simpson et al., 2010a), partially rescued UVB-induced reduction in differentiation markers in 
both monolayer cells and organotypic epidermal models. HDAC inhibitors may therefore be 
useful treatments for enhancing epidermal differentiation after acute UVB exposure, with 
potential applications for skin cancer prevention.  
 
Results: 
 
Acute UVB exposure of keratinocytes prior to induction of differentiation results in 
decreased expression of differentiation-associated proteins: To examine the impact of UVB 
© 2014 The Society for Investigative Dermatology
Johnson et al., Page 6 
 
exposure on differentiation-dependent desmosomal cadherins and keratins in early epidermal 
differentiation, normal human epidermal keratinocytes (NHEKs) were exposed to increasing 
dosages of UVB prior to switching to high calcium medium to induce differentiation. A 
reduction in both Dsg1 and Dsc1 was observed when NHEKs were exposed to 1000, 2000 or 
3000 J/m
2
 UVB prior to calcium switch, while other cadherins Dsg3 and Ecad were not affected 
(Fig. 1a). Differentiation-associated keratins K10 and K1 as well as Pg levels were also reduced 
after exposure to the higher UVB dosages. An increase in phosphorylated Erk (pErk) was 
observed at the same UVB dosages associated with decreased differentiation markers. Thus the 
viable cells remaining after acute UVB exposure exhibited an increase in pro-proliferative 
signaling (Dumesic et al., 2009).  
 
To determine the level of cell death induced by the acute UVB dosages, apoptotic cells 
were assessed using the Terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) assay 48 hours after UVB exposure. The remaining viable cells per microscopic field 
were also counted. 2000 J/m
2
 UVB exposure resulted in less than 3% of cells undergoing 
apoptosis at the 48 hour time point and approximately 2/3 of the cells remaining compared to 
unexposed controls, while exposure to 3000 J/m
2
 UVB resulted in approximately 8% of cells 
undergoing apoptosis and 1/3 of the cells remaining (Fig. 1b).  
 
The morphology of organotypic cultures exposed to the same UVB regimen after 
differentiation and stratification had occurred was also analyzed for comparison (Supplemental 
Fig. 1 exposed on day 6 and harvested on day 7 after lifting, see timeline). Acanthosis of the 
stratum corneum and increased intercellular spaces, particularly in the lower epidermal layers, 
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were observed in the cultures exposed to 1000 J/m
2 
UVB. Sunburn cells were apparent in the 
cultures exposed to 1500 J/m
2
 and increased in number with the higher UVB dosages. The 
stratum corneum and granular layers, and the expression and distribution of Dsg1, Dsc1, and 
loricrin were disturbed in the cultures exposed to UVB dosages from 1500 to 3000 J/m
2
, 
consistent with defects in differentiation. 
 
Dsg1 promotes epidermal differentiation and architectural recovery after UVB exposure: 
We previously demonstrated that Dsg1 promotes epidermal differentiation through attenuation of 
Erk1/2 signaling (Getsios et al., 2009). To address whether loss of Dsg1 exacerbates reduction in 
differentiation after UVB exposure, Dsg1 was depleted in NHEKs via shRNA. Knocking down 
Dsg1 resulted in more pronounced reductions in Dsc1, K10, and K1 at UVB dosages as low as 
500 J/m
2
 and almost total loss of detectable Dsc1, K10, or K1 proteins in NHEKS exposed to 
2000 or 3000 J/m
2
 UVB (Fig. 2a right). In control-infected NHEKs, as in uninfected NHEKs in 
Fig. 1, exposure to 2000 or 3000 J/m
2
 UVB resulted in reduction of Dsg1, Dsc1, K10, and K1 
(Fig. 2a left). Thus Dsg1 loss exacerbated the reduction in keratinocyte differentiation markers in 
a UVB dose-dependent manner. 
 
To understand the impact of Dsg1 loss on the recovery of proper epidermal architecture 
after UVB exposure, organotypic cultures were grown from NHEKs infected with control or 
Dsg1 shRNA. The cultures were exposed to 1000 J/m
2
 UVB on day 6 after lifting to the air-
liquid interface and then allowed to recover for either 24 hours or 7 days (see timeline). In 
control-infected organotypic cultures, the number of cells staining positive for Dsg1 was reduced 
24 hours after UVB exposure compared to unexposed cultures, but Dsg1 expression was restored 
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by the later time point (Fig 2b, left panels). Seven days after UVB exposure in the Dsg1-depleted 
organotypic cultures, the thickness of the viable epithelial portion was reduced compared to 
controls. A thickened, disorganized stratum corneum accumulated, exhibiting remnants of cell 
nuclei (Fig. 2b, right panels). Dsg1 was therefore important for recovery of proper epidermal 
model architecture after UVB exposure. 
 
To determine whether increasing Dsg1 expression would help restore expression of other 
differentiation-associated proteins after UVB exposure, NHEKs were infected with viruses 
expressing either GFP control or ectopic Dsg1. Ectopic Dsg1 expression resulted in increased 
Dsc1, K10, and K1 expression 48 hours after UVB exposure compared to controls (Fig. 2c). The 
data indicated that Dsg1 was important for regulating expression of other differentiation markers 
after UVB exposure. 
 
UVB-induced delay in differentiation and reduced Dsg1 mRNA levels are associated with 
decreased binding of p63 to regulatory regions upstream of the Dsg1 gene: The effects of 
UVB exposure on expression of differentiation markers could be at the level of protein stability, 
gene transcription, or both. To test whether UVB exposure resulted in a delay in induction of 
differentiation marker expression, NHEKs were either unexposed (Fig. 3a) or exposed to 2000 
J/m
2
 UVB (Fig. 3b) immediately prior to calcium switch to induce differentiation and harvested 
at 4 or 12 hour intervals beginning at 48 hours. While Dsg1 protein was detectable as early as 48 
hours after calcium switch in the unexposed cells, it remained difficult to detect until 72 hours in 
the UVB-exposed NHEKs. Other differentiation markers Dsc1, K10, and K1 were detectable by 
60 hours in the unexposed cells while remaining difficult to detect until 72 hours in the UVB-
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exposed NHEKs. Quantitative RT-PCR revealed that Dsg1 transcript levels were reduced as 
early as 5 hours and remained reduced 72 hours after calcium switch in UVB-exposed NHEKs 
compared to unexposed controls.  
 
 The master regulator of epidermal differentiation, p63 (Koster, 2010), was recently 
shown to bind to a mouse Dsg1 gene regulatory region to induce Dsg1 transcription (Ferone et 
al., 2013). Thus, we reasoned that p63-induced transcription of Dsg1 may be impacted by 
exposure of NHEKs to UVB. To identify p63 binding sites in the human Dsg1 genomic locus, 
previously generated ChIP-seq data obtained in human keratinocytes (Kouwenhoven et al., 
2010) were analyzed. Three p63-binding regions (-25Kb, -60Kb, -70Kb) were identified 
upstream of the gene and corresponded to genomic regions enriched in positive histone marks 
associated with active transcription, and to clusters of DNase hypersensitive sites (Supplemental 
Fig. 2a) (Bernstein et al., 2005; Sabo et al., 2006). Using Chromatin Immunoprecipitation (ChIP) 
to test binding of p63 to these putative regions resulted in the finding that p63 preferentially 
bound to the regulatory region 60kB from the human Dsg1 gene (Fig. 3d) and bound to a lesser 
extent to the other regions (Supplemental Fig. 2b). p63 binding to these regulatory regions was 
decreased following exposure of NHEKs to 2000 J/m
2
 UVB (Fig. 3d and Supplemental Fig. 2b), 
correlating with the UVB-induced reduction in Dsg1 transcripts.  
 
Treatment of cultures with the HDAC inhibitor TSA increases differentiation marker 
expression after UVB exposure: Since previous studies showed that treatment of cells with the 
HDAC inhibitor TSA increases expression of desmosomal cadherins (Simpson et al., 2010a) 
experiments were conducted to determine if TSA treatment after UVB exposure would rescue 
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Dsg1 expression. Indeed, TSA treatment increased Dsg1 and Dsc1 expression in monolayer 
cultures (Supplemental Fig. 3) and Dsg1, Dsc1, and K10 expression in organotypic epidermal 
cultures (Fig. 4a) after UVB exposure compared to UVB-exposed untreated or DMSO treated 
controls. This was not through an increase in p63 binding to the Dsg1 gene regulatory regions 
(data not shown). TSA treatment also reduced UVB-induced phosphorylation of Erk compared 
to DMSO-treated controls (Fig 4b). 
 
Discussion: 
 
From these studies we conclude that Dsg1 promotes differentiation and structural repair 
of UVB-damaged epidermis. Further, our work shows that a clinically relevant HDAC inhibitor, 
TSA, increases Dsg1 expression and helps restore epidermal differentiation following acute 
UVB exposure. This work is important, as cumulative sun exposure and childhood sunburns 
significantly correspond with increased risk of skin carcinogenesis in adulthood (English et al., 
1998), and UV-induced alterations in epidermal structural proteins may contribute to retention of 
mutated cells within the skin structure that later become cancerous. For example, loss of Dsg1 
and differentiation-associated proteins filaggrin and occludin, have been associated with a 
reduction in UV-mediated apoptosis (Dusek et al., 2006; Mildner et al., 2010; Rachow et al., 
2013). Filaggrin loss also results in increased UV-induced DNA damage (Mildner et al., 2010). 
In the present study increased Erk phosphorylation was observed at the same UVB dosages 
where differentiation markers were reduced, consistent with the idea that surviving cells that do 
not undergo differentiation activate Erk pathway-mediated pro-proliferative signaling (Dumesic 
et al., 2009). Treatment of organotypic cultures with TSA reduced UVB-induced 
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phosphorylation of Erk while promoting expression of Dsg1 and associated differentiation 
proteins. We propose that therapeutically increasing expression of Dsg1 to promote restoration 
of differentiation markers (Getsios et al., 2009) as well as to repress pro-oncogenic 
EGFR/MAPK/ras signaling (Getsios et al., 2009; Hammers and Stanley, 2013; Harmon et al., 
2013) may help prevent skin carcinogenesis.  
 
In addition to skin cancer, UV exposure can initiate or exacerbate the pathology of other 
human skin diseases. For example, UV exposure induces acantholysis in the uninvolved skin of 
patients with pemphigus foliaceus, pemphigus vulgaris, and pemphigus erythematosus, disorders 
caused by auto-antibodies against Dsg1 or Dsg3 (Cram and Winkelmann, 1965; Igawa et al., 
2004; Jacobs, 1965; Kawana and Nishiyama, 1990; Makino et al., 2013; Reis et al., 2000). This 
was posited to be due to increased IgG deposits in intercellular spaces within the UV-induced 
lesions (Cram and Fukuyama, 1972). However, Dsg1 levels or localization were not examined to 
determine whether UV exposure exacerbates pemphigus antibody-induced depletion of Dsg1 
from desmosomes. Studies are warranted to understand how decreases in Dsg1, Dsc1, K1, and 
K10 following UVB exposure may contribute to the pathologies of these and other more 
common epidermal diseases like psoriasis and eczema. There are reports of psoriasis patients 
developing pemphigus lesions following phototherapy and the underlying mechanisms remain 
unexplained (Kwon et al., 2011; Sanchez-Palacios and Chan, 2004).  
 
Therapeutically stabilizing Dsg1 in UV-exposed skin through use of HDAC inhibitors or 
other drugs could reduce symptoms of patients suffering from several skin diseases as well as 
potentially preventing skin carcinogenesis. HDAC inhibitors are in clinical trials as anti-cancer 
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agents. Two have been approved by the Food and Drug Administration for use against cutaneous 
T cell lymphomas, and several are being explored for treating psoriasis (Khan and La Thangue, 
2012; Shuttleworth et al., 2010). Therefore, use of these agents to help restore epidermal 
differentiation after acute sun exposure may be feasible. 
 
Materials and Methods: 
 
Cell culture and retroviral transduction 
NHEKs were isolated from neonatal foreskin by the Northwestern University Skin Disease 
Research Center (NUSDRC) as described (Halbert et al., 1992). Cells were propagated in M154 
medium supplemented with human keratinocyte growth supplement (HKGS, Life Technologies, 
Grand Island, NY, USA), 1,000× gentamycin/amphotericin B solution (Life Technologies), and 
0.07 mM CaCl2 (low calcium). Confluent keratinocyte monolayers were induced to differentiate 
by addition of 1.2 mM CaCl2 (high calcium) in M154 in the absence of HKGS. LZRS-GFP, 
LZRS-Flag Dsg1, LZRS-miR Dsg1, and LZRS-miR Lamin (control) were generated as 
previously described (Getsios et al., 2004; Getsios et al., 2009). Keratinocytes were transduced 
with retroviral supernatants produced from Phoenix cells (provided by G. Nolan, Stanford 
University, Stanford, CA) as previously described (Getsios et al., 2004; Simpson et al., 2010a). 
For organotypic cultures, keratinocytes were seeded on collagen/fibroblast matrices and grown 
submerged in E medium supplemented with 5 ng/ml epidermal growth factor (EGF) for two 
days, then grown at the air–medium interface in E medium without EGF according to published 
protocols (Simpson et al., 2010a; Simpson et al., 2010b).  
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UVB exposure 
Cells (in sufficient Phosphate Buffered Saline - PBS - to minimally cover the culture plate 
surface) or organotypic cultures (raised to the air/liquid interface) were irradiated under two 
TL20W/01 narrow band UVB bulbs with peak irradiance at 311 nm wavelength (Solarc Systems, 
Inc, Barrie, ON, Canada). The exposure time required to obtain UVB doses (J/m
2
) was calculated 
by measuring W/cm
2
 using an ILT1400A photometer (International Light Technologies, 
Peabody, MA) calibrated by the manufacturer. The photometer is equipped with detectors to 
measure UVB and UVC and no UVC was emitted from the UVB bulbs. For a clinical 
comparison of UVB dosages used throughout this study, depending upon skin type (age, 
pigmentation, thickness), 4000 J/m
2
 UVB is considered 1 Minimal Erythemal Dose (MED) (van 
der Vleuten et al., 1996). 
 
Antibodies and reagents 
Mouse monoclonal antibodies used: P124 (anti–Dsg1 extracellular domain; Progen, Heidelberg, 
Germany); 27B2 (anti–Dsg1 cytodomain; Invitrogen), U100 (anti-Dsc1; Progen), HECD1 (anti–
E-cadherin; Takara, Kyoto, Japan) and 4A4 (anti-p63; Santa Cruz Biotechnology, Dallas, TX). 
Rabbit polyclonal antibodies used: K1, K10, and loricrin (gifts from J. Segre, National Human 
Genome Research Institute, Bethesda, MD), 1905 (anti-Dsg3; gift from J. Stanley, University of 
Pennsylvania, Philadelphia, PA), C33E10 (anti-pERK; Cell Signaling Technology, Danvers, 
MA),  anti-Erk1/2 (Promega, Madison, WI), H-137 (anti-p63; Santa Cruz Biotechnology) and 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase; Sigma-Aldrich). Chicken polyclonal 
antibody used: Pg (1407; Aves Laboratories, Tigard, OR). Secondary antibodies for 
immunoblotting were goat anti–mouse, –rabbit, and –chicken peroxidase (Rockland; KPL, 
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Gaithersburg, MD). Secondary antibodies for immunofluorescence microscopy were goat anti–
mouse, –rabbit, and –chicken linked to fluorophores of 488 nm and 568 nm (Alexa Fluor; 
Invitrogen).  
 
Immunoblot analysis of proteins 
Whole cell or organotypic culture lysates were collected in Urea-SDS buffer (8M Urea/ 1% 
Sodium dodecyl sulfate/ 60 mM Tris pH 6.8/ 5% -mercaptoethanol/ 10% glycerol) and 
sonicated. Samples separated by SDS-PAGE were transferred to nitrocellulose, blocked in 5% 
milk/PBS, and probed with primary antibody in milk for 1 hour at room temperature. Secondary, 
HRP-conjugated antibodies diluted 1:5000 in milk were added to blots after washing with PBS. 
Protein bands were visualized using enhanced chemiluminescence and exposure to X-ray film. 
 
Quantitative real-time PCR 
RNA was isolated using the RNeasy Mini kit (Qiagen, Valencia, CA), according to the 
manufacturer’s instructions. Total RNA concentrations were equalized between samples, and 
cDNA prepared using the Superscript III First Strand kit (Invitrogen). Quantitative PCR was 
performed using SYBR Green PCR master mix (Applied Biosystems) and gene-specific primers 
in a StepOnePlus instrument (Applied Biosystems). Calculations for relative mRNA levels were 
performed using the ΔΔCt method, normalized to GAPDH. Primers used: Dsg1F 
TCCATAGTTGATCGAGAGGTCAC, Dsg1R CTGCGTCAGTAGCATTGAGTATC, 
GAPDHF ACATCGCTCAGACACCATG, GAPDHR TGTAGTTGAGGTCAATGAAGGG. 
 
ChIP 
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NHEKs were fixed with 1% formaldehyde and ChIP was performed using anti-p63 antibodies 
with rabbit IgG antibodies as a negative control. ChIP was performed as previously described 
(Antonini et al., 2010). Real-time PCR was performed using the SYBR Green PCR master mix 
(Applied Biosystems) in an ABI PRISM 7500. 
Primers used: -25kbDsg1F TCTCTCAACCTGCACTCAATCTG, -25kbDsg1R 
GGGAGGCTTCTCTGCGATTA, -60kbDsg1F GGGCAATGACATCCCTTGTT, -60kbDsg1R 
GGTGTGTTCTGCAAGTTCCACTT, -70kbDsg1F TTAAGCAAAACTAATGGACCACAGA 
-70kbDsg1R GCTCATGCATGTTCATATACAAACC. 
 
Histology, indirect immunofluorescence microscopy 
Organotypic cultures fixed in 10% neutral buffered formalin were embedded in paraffin blocks, 
cut into 5 m sections, and H&E stained by the NUSDRC. For indirect immunofluorescence 
microscopy, slides were baked at 60
o
C, de-paraffinized by xylenes, dehydrated with ethanol, 
rehydrated in PBS and permeablized by 0.5% Triton X-100 in PBS. Antigen retrieval was 
performed by incubation in 0.01 M Citrate buffer (pH 6.0) or 0.5 M Tris buffer (pH 8.0) at 95
o
C 
for 15 minutes. Sections were blocked in 1% BSA/0.05% Tween/PBS for 30 minutes at 37
o
C. 
Primary antibody incubation was carried out overnight at 4
o
C in blocking buffer followed by 
washing in PBS. Secondary antibody incubation was carried out at 37
o
C for 45 minutes followed 
by washing in PBS. Sections were stained with 4′,6-Diamidino-2-phenylindole (DAPI - Sigma-
Aldrich) at a final concentration of 5 ng/ l at room temperature for 2 minutes followed by 
washing in PBS and water. Cover slips were mounted with ProLong Gold Antifade Reagent 
(Life Technologies). Images were obtained with a 40x PL Fluotar, NA 1.0 objective on a Leica 
DMR microscope using a charge-coupled device camera (Orca 100, model C4742-95, 
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Hamamatsu, Bridgewater, NJ) and MetaMorph 6.1 software (MDS Analytical Technologies, 
Union City, CA) for fluorescence or a Leica DFC320 digital camera and Photoshop software 
(Adobe Systems, Mountain View, CA) for H&E images. 
 
TUNEL assay 
Cells undergoing apoptosis 48 hours following UVB exposure were detected using the in situ 
Cell Death Detection Kit (Roche, Penzberg, Germany) according to the manufacturer’s protocol. 
The total cells per microscopic field were detected using DAPI.  
 
HDAC Inhibition  
On the day of lifting to the air-liquid interface organotypic models were left unexposed or 
exposed to 1500 J/m2 UVB on ice. Beginning the next day organotypic cultures were left 
untreated or treated with Dimethyl sulfoxide (DMSO) (Sigma-Aldrich) or TSA (1 μmol/L, 
Sigma-Aldrich) for 4 hours daily. Cultures were harvested on day 4 after lifting. Confluent cells 
were unexposed or exposed to 2000 J/m
2
 UVB immediately prior to switching to 1.2 mM CaCl2 
containing medium. The next day cells were either left untreated or treated with DMSO or TSA 
in fresh high calcium-containing medium and harvested 72 hours after calcium switch.  
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Figure legends: 
 
Figure 1: Acute UVB exposure of keratinocytes prior to induction of differentiation results 
in decreased expression of differentiation-associated proteins: a) Immunoblots showing 
differentiation-associated proteins reduced in NHEKs exposed to UVB prior to inducing 
differentiation. Numbers under immunoblots represent band intensity fold change from no UVB 
control after normalization to GAPDH. b) Level of cell death induced by UVB dosages utilized 
throughout this study assessed using either the TUNEL assay or by counting the total number of 
cells per microscopic field 48 hours after UVB exposure. 
 
Figure 2: Dsg1 promotes epidermal differentiation and architectural recovery after UVB 
exposure: a) Immunoblots showed that shRNA-mediated depletion of Dsg1 further reduced 
Dsc1, K10, and K1 compared to control NHEKs exposed to UVB prior to calcium switch. 
Numbers represent band intensity fold change from unexposed shCon-infected cells after 
normalization to GAPDH. b) Dsg1 depletion altered the architecture of UVB-exposed 
organotypic models compared to controls (H&E). Organotypic models were grown for 6 days 
before mock exposure or irradiation with 1000 J/m
2
 UVB then harvested 1 or 7 days later. Bars = 
50 m. c) Dsc1, K10, and K1 proteins were expressed at higher levels when Dsg1 was 
ectopically expressed in UVB-exposed differentiating NHEKs compared to controls. Numbers 
represent band intensity fold change from unexposed GFP-infected cells after normalization to 
GAPDH. 
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Figure 3: UVB-induced delay in differentiation and reduced Dsg1 mRNA levels are 
associated with decreased binding of p63 to regulatory regions upstream of the Dsg1 gene: 
a-b) Initiation of Dsg1, Dsc1, K1, and K10 protein expression was delayed following exposure to 
UVB compared to unexposed control NHEKs. c) Dsg1 transcript levels remained reduced up to 
72 hours in NHEKs following UVB exposure (2000 J/m
2
 prior to calcium switch to induce 
differentiation) compared to unexposed controls. d) The binding of p63 to an enhancer regulatory 
region -60kB from the Dsg1 gene was reduced following UVB exposure. NHEKs were 
unexposed or exposed to 2000 J/m
2
 UVB prior to calcium switch then harvested 29 or 48 hrs 
later and processed for ChIP. Immunoblot shows total p63 levels after UVB exposure. 
 
Figure 4: Treatment of epidermal models with the HDAC inhibitor TSA increases 
differentiation marker expression after UVB exposure: a) Organotypic models were 
unexposed or exposed to 1500 J/m
2
 UVB prior to lifting to the air-liquid interface, left untreated 
or treated with DMSO or TSA for 4 hours daily starting 24 hours later, then harvested 4 days 
after lifting. Numbers represent band intensity fold change comparing unexposed treated and 
untreated cultures and comparing UVB-exposed treated and untreated cultures after 
normalization to GAPDH. Immunoblots revealed that TSA treatment helped restore Dsg1, Dsc1, 
and K10 expression after UVB exposure. b) TSA treatment reduces phosphorylated Erk in UVB-
exposed organotypic cultures compared to DMSO treated controls. 
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